<html class="no-js" lang="en">
    <head>
    <meta charset="utf-8">
  
    <meta http-equiv="x-ua-compatible" content="ie=edge">
    <title>Patient Education l Dr.Nikita's Eye Hospital                 Clinic</title>
    <meta name="robots" content="noindex, follow">
    <link rel="canonical" href="https://risingretina.matrixpanel.in/patient-education.html" />
    <meta name="description" content="Empower yourself with valuable information on eye health and treatment options through patient education resources available at Dr.Nikita's Eye Hospital                 Clinic.">
    <meta name="keywords" content="Patient Education , Dr.Nikita's Eye Hospital                 Clinic in Ahmedabad, Rising ratina Clinic in Gujarat, Vision care in Ahmedabad, Retina Eye Surgery Specialist in Ahmedabad"/>
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <!-- Favicon -->
       <link rel="shortcut icon" type="image/x-icon" href="images/logo.jpg">
    <!-- CSS
       ============================================ -->
    <!-- Bootstrap CSS -->
    <link rel="stylesheet" href="css/bootstrap.min.css">
    <!-- Fontawesome -->
    <!-- <link rel="stylesheet" href="css/fontawesome.css"> -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.css" integrity="sha512-5A8nwdMOWrSz20fDsjczgUidUBR8liPYU+WymTZP1lmY9G6Oc7HlZv156XqnsgNUzTyMefFTcsFH/tnJE/+xBg==" crossorigin="anonymous" referrerpolicy="no-referrer" />
    <!-- Flaticon -->
    <link rel="stylesheet" href="css/flaticon.css">

    <!-- optico Icons -->
    <link rel="stylesheet" href="css/pbminfotech-base-icons.css">
    <!-- Themify Icons -->
    <link rel="stylesheet" href="css/themify-icons.css">
    <!-- Slick -->
    <link rel="stylesheet" href="css/swiper.min.css">
    <!-- Magnific -->
    <link rel="stylesheet" href="css/magnific-popup.css">
    <!-- AOS -->
    <link rel="stylesheet" href="css/aos.css">
    <!-- Shortcode CSS -->
    <link rel="stylesheet" href="css/shortcode.css">
    <!-- Base CSS -->
    <link rel="stylesheet" href="css/base.css">
    <!-- Style CSS -->
    <link rel="stylesheet" href="css/style.css">
    <!-- Responsive CSS -->
    <link rel="stylesheet" href="css/responsive.css">
    <!-- REVOLUTION STYLE SHEETS -->
    <link rel="stylesheet" type="text/css" href="revolution/rs6.css">

 </head>
 <style>
   .tab {
   /* Your tab styles here */
}

.tab.active {
   /* Your active tab styles here */
}

.tab-content {
   display: none;
   /* Your tab content styles here */
}

.tab-content.active {
   display: block;
   /* Your active tab content styles here */
}
 </style>

 <body data-aos-easing="ease" data-aos-duration="400" data-aos-delay="0">
    <!-- page wrapper -->
    <div class="page-wrapper">

       <!-- Header Main Area -->
       <header class="site-header header-style-1">
          <div class="site-header-menu">
             <div class="container-fuild">
                <div class="d-flex align-items-center justify-content-between">
                   <div class="site-branding">
                      <!-- Logo area -->
                      <h1 class="site-title">
                         <a href="index.html" rel="home">
                            <img class="logo-img" src="images/logo.png" alt="Cardioly Demo1" title="Cardioly Demo1">
                         </a>
                      </h1>				        
                   </div>
                   <div class="flex-grow-1">
                      <div class="pre-header">
                         <div class="container-fuild">
                            <div class="d-md-flex justify-content-between">
                               <div class="pbmit-pre-header-left">
                               <span class="pbmit-label"> <a href="index.html">Home</a> 
                            
                                  </span>
                                <span class="pbmit-label"><a href="/inquiry.php">Inquiry</a></span>
                             <span class="pbmit-label"><a href="contact.html">Contact Us</a></span>
                               </div>
                               <div class="pbmit-pre-header-right">
                                  <ul class="pbmit-contact-info d-flex align-items-center">
                                     <li>
                                        <a href="mailto:docnikitaspatel@gmail.com"> <i class="fa fa-envelope" aria-hidden="true"></i> Email  : docnikitaspatel@gmail.com</a>
                                     </li>
                                     <li>
                                        <i class="fa fa-phone" aria-hidden="true"></i> Phone : +91 79 9072 3404                                     </li>
                                     <li>
                                        <ul class="pbmit-social-links d-flex align-items-center">
                                           <li class="pbmit-social-li pbmit-social-facebook">
                                              <a href="https://www.facebook.com/profile.php?id=100054410862900&mibextid=LQQJ4d" target="_blank">
                                                <i class="fa fa-facebook-f"></i>
                                              </a>
                                           </li>
                                           <li class="pbmit-social-li pbmit-social-twitter">
                                              <a href="https://www.instagram.com/dr.nikita_eye_hospital/?igshid=YmMyMTA2M2Y%3D" target="_blank">
                                                <i class="fa fa-instagram"></i>
                                              </a>
                                           </li>
                                           <!-- <li class="pbmit-social-li pbmit-social-linkedin">
                                              <a href="#" target="_blank">
                                                 <i class="pbmit-base-icon-linkedin-squared"></i>
                                              </a>
                                           </li>
                                           <li class="pbmit-social-li pbmit-social-youtube">
                                              <a href="#" target="_blank">
                                                 <i class="pbmit-base-icon-youtube-play"></i>
                                              </a>
                                           </li> -->
                                        </ul>
                                     </li>
                                  </ul>						
                               </div>
                            </div>
                         </div>
                      </div>
                      <div class="site-header-menu-inner">
                         <div class="container-fuild">
                            <div class="row">
                               <div class="col-md-12">
                                  <div class="d-flex justify-content-between">
                                     <div class="site-navigation ml-auto">

                                       <nav class="main-menu navbar-expand-xl navbar-light">
                                          <div class="navbar-header">
                                             <!-- Toggle Button --> 
                                             <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
                                                <!-- <i class="pbmit-base-icon-menu-1"></i> -->
                                                <i class="fa fa-bars"></i>
                                             </button>
                                          </div>
                                          <div class="collapse navbar-collapse clearfix" id="navbarSupportedContent">
                                             <ul class="navigation clearfix">
                                                <li class="dropdown d-xl-none">
                                                   <a href="index.html">Home</a>
                                  
                                               </li>

<li class="dropdown d-xl-none">
                                                   <a href="/inquiry.php">Inquiry</a>
                                  
                                               </li>

<li class="dropdown d-xl-none">
                                                   <a href="contact.html">Contact Us</a>
                                  
                                               </li>
<li class="dropdown ">
                                                   <a href="overview.html">Overview</a>
                                  
                                               </li>
                                                <li class="dropdown">
                                                   <a href="technology.html">Technology</a>
         
                                         </li>
                                                
                                                <!-- <li class="dropdown">
                                                   <a href="#">Service</a>
                       
                                                <span class="righticon"><i class="fa fa-angle-down"></i></span></li> -->
                                                
                                                <li class="dropdown">
                                                   <a href="infrastructure.html">Infrastructure</a>

                                               </li>
                                               <li class="dropdown ">
                                                   <a href="patient.html">Patient Information</a>

                                              </li>
                                              <li >
                                               <a href="patient-services.html">Patient Services</a>

                                               </li>
                                               <li class="active"><a href="patient-education.html">Patient Education</a>
                                               </li>
                                             </ul>
                                          </div>
                                       </nav>

                 
                                     </div>
                                     <div class="pbmit-right-box">
                                        <!-- <div class="pbmit-header-search-btn">
                                           <a href="#"><i class="fa fa-search" aria-hidden="true"></i></a>
                                        </div> -->
                                        <div class="menu-right-box d-flex align-items-center">
                                           <div class="pbmit-header-button">
                                              <a href="inquiry.php" class="pbmit-btn">Appointment</a>
                                           </div>
                                        </div>
                                     </div>
                                  </div>
                               </div>
                            </div>
                         </div>
                      </div>
                   </div>
                </div>
             </div>
          </div>
         

        
          </div>
       </header>


       <div class="pbmit-title-bar-wrapper position-relative">
         <div class="img-cover">
            <img src="images/bg/patient-education.png" alt="" class="w-100 d-none d-sm-block" srcset="">
            <img src="images/bg/patient-education-mob.png" alt="" class="d-block d-sm-none w-100" srcset="">
         </div>
         
        <div class="container banner-container">
         <div class="pbmit-title-bar-content">
            <div class="pbmit-title-bar-content-inner">
               <div class="pbmit-tbar">
                  <div class="pbmit-tbar-inner container">
                     <h1 class="pbmit-tbar-title"> Transforming Vision Health <br/> at Dr.Nikita's Eye Hospital                </h1>
                  </div>
               </div>
               <div class="pbmit-breadcrumb">
                  <div class="pbmit-breadcrumb-inner">
                     <span><a title="" href="/" class="home"><span>Dr.Nikita's Eye Hospital                 Clinic</span></a></span>
                     <span class="sep"><i class="fa fa-angle-right" aria-hidden="true"></i></span>
                     <span><span class="post-root post post-post current-item">Patient Education</span></span>
                  </div>
               </div>
            </div>
         </div>
        </div>
     </div>




       <!-- Header Main Area End Here -->

       <!-- Page Content -->
       <div class="page-content">

 

         <!-- <section>
            <div class="container">
               <div class="row">
                  <div class="col-lg-3 service-left-col order-2 order-lg-1">
                     <aside class="service-sidebar">
                        <aside class="widget post-list">
                           <div class="all-post-list">
                              <ul>
                                 <li class="post-active"><a href="patient-education.html"> Diabetic Retinopathy (DR)</a></li>
                                 <li ><a href="retinal.html">  Retinal Detachment </a></li>
                                 <li ><a href="age.html"> Age Related Macular Degeneration (AMD) </a></li>
                                 <li ><a href="brvo.html">Branch Retinal Vein Occlusion (BRVO)</a></li>
                                 <li ><a href="crvo.html">Central Retinal Vein Occlusion (CRVO)</a></li>
                                 <li ><a href="crao.html">Central Retinal Artery Occlusion (CRAO)</a></li>
                                 <li ><a href="csr.html">Central Serous Retinopathy (CSR)</a></li>
                                 <li ><a href="macular_edema.html">Macular Edema</a></li>
                                 <li ><a href="macular_hole.html">Macular Hole</a></li>
                                 <li ><a href="macular_pucker.html">Macular Pucker</a></li>
                                 <li ><a href="rp.html">Retinitis Pigmentosa (RP)</a></li>
                                 <li ><a href="toxoplasmosis.html">Toxoplasmosis</a></li>
                                 <li ><a href="lattice.html">Lattice Degeneration</a></li>
                                 <li ><a href="floater.html">Floaters & Flashes</a></li>
                
                              </ul>
                           </div>
                        </aside>


                     </aside>
                  </div>
                  <div class="col-lg-9 service-right-col order-1">

                     <div class="about-left-section">
 
 
                 
                  </div>
               </div>
            </div>
         </section> -->


         <section>
            <div class="container">
               <div class="row">
                  <div class="col-lg-3 service-left-col ">
                     <aside class="service-sidebar">
                        <aside class="widget post-list">
                           <div class="all-post-list">
                              <div id="tab-container">
                                 <ul>

                                    <li class="tab post-active"><a href=""> Diabetic Retinopathy (DR)</a></li>
                                    <li class="tab"><a href=""> Retinal Detachment </a></li>
                                    <li class="tab"><a href=""> Age Related Macular Degeneration (AMD) </a></li>
                                    <li class="tab"><a href="">Branch Retinal Vein Occlusion (BRVO)</a></li>
                                    <li class="tab"><a href="">Central Retinal Vein Occlusion (CRVO)</a></li>
                                    <li class="tab"><a href="">Central Retinal Artery Occlusion (CRAO)</a></li>
                                    <li class="tab"><a href="">Central Serous Retinopathy (CSR)</a></li>
                                    <li class="tab"><a href="">Macular Edema</a></li>
                                    <li class="tab"><a href="">Macular Hole</a></li>
                                    <li class="tab"><a href="">Macular Pucker</a></li>
                                    <li class="tab"><a href="">Retinitis Pigmentosa (RP)</a></li>
                                    <li class="tab"><a href="">Toxoplasmosis</a></li>
                                    <li class="tab"><a href="">Lattice Degeneration</a></li>
                                    <li class="tab"><a href="">Floaters & Flashes</a></li>


                                 </ul>
                              </div>
                           </div>
                        </aside>
                     </aside>
                  </div>
                  <div class="col-lg-9 service-right-col order-1">
                     <div class="about-left-section">
                        <div class="tab-content active">
                           <div class="about-left-section">


                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><h2>Diabetic Retinopathy</h2></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                   <ul style="list-style: disc;padding-left: 20px;"><li><span dir="ltr"><em>What is diabetes </em>!! -  Diabetes mellitus is the inability of the body to use and store sugar properly,  resulting in high blood glucose (sugar) levels</span></li>
                                   <li><span dir="ltr">Diabetes results in damage to  veins, arteries and capillaries throughout the body.</span></li>
                                   <li><span dir="ltr">Diabetes affecting vision – <strong></strong></span>
                                    <ul style="list-style: circle;padding-left: 20px;">
                                      <li><span dir="ltr">Increases the likelihood of cataracts</span></li>
                                      <li><span dir="ltr">Increases the risk glaucoma</span></li>
                                      <li><span dir="ltr">Risk of developing diabetic retinopathy: damage occurs to the fragile blood vessels of the retina </span></li>
                                    </ul>
                                  </li>
                                   <li><span dir="ltr">Diabetic retinopathy is a leading  cause of new cases of blindness in people aged 20 to 74 years</span></li>
                                   </ul>
                                  <br>
                                  <u><h4>Etiology</h4></u>
                                   <ol>
                                     <li><span dir="ltr">The duration of diabetes:</span></li>
                                    <ul style="list-style: circle;padding-left: 20px;">
                                      <li><span dir="ltr">It is the most important factor.</span></li>
                                      <li><span dir="ltr">In patients diagnosed as having  diabetes before the age of 30 years, the incidence of DR :</span></li>
                                       <ul style="list-style: disc;padding-left: 20px;">
                                         <li><span dir="ltr">After 10 years is 50%</span></li>
                                         <li><span dir="ltr">After 30 years is&nbsp; 90%</span></li>
                                       </ul>
                                    </ul>
                                   <li><span dir="ltr">Glycemic  control:</span></li>
                                    <ul style="list-style: circle;padding-left: 20px;">
                                      <li><span dir="ltr">Increased severity of diabetic retinopathy is associated with poorer glucose control</span></li>
                                    </ul>
                                   <li><span dir="ltr">Miscellaneous factors:</span></li>
                                    <ul style="list-style: circle;padding-left: 20px;">
                                      <li><span dir="ltr">Pregnancy</span></li>
                                      <li><span dir="ltr">Systemic Hypertension</span></li>
                                      <li><span dir="ltr">Renal Disease</span></li>
                                      <li><span dir="ltr">Anaemia.(↓Oxygen )</span></li>
                                      <li><span dir="ltr">Elevated Serum lipid.</span></li>
                                      <li><span dir="ltr">Aarotid artery occlusive disease</span></li>
                                      <li><span dir="ltr">Alcohol</span></li>
                                      <li><span dir="ltr">Obesity</span></li>
                                    </ul>
                                   <li><span dir="ltr">PVD: degenerative changes in vitreous</span></li>
                                   <li><span dir="ltr">High myopia</span></li>
                                   <li><span dir="ltr">Removal of cataract</span></li>
                                    </ol>
                                  <br>
                            <u><h4>Ophthalmic Features</h4></u>
                                    <ol>
                                     <li><span dir="ltr"><strong>Microaneurysms</strong></span></li>
                                   <ul style="list-style: circle;padding-left: 20px;">
                                     <li><span dir="ltr">Located in  the inner nuclear layer.</span></li>
                                     <li><span dir="ltr">The first  clinically detectable lesions.</span></li>
                                     <li><span dir="ltr">Small round  dots .(20-200 μ)</span></li>
                                     <li><span dir="ltr">Mostly located  near and temporal to the macula.</span></li>
                                     <li><span dir="ltr">When coated  with blood they may be indistinguishable from dot haemorrhages.</span></li>
                                  </ul>
                                     <li><span dir="ltr"><strong>Haemorrhages</strong> : The clinical  appearance depending on location</span></li>
                                  <ul style="list-style: circle;padding-left: 20px;">
                                     <li><span dir="ltr">'Dot' and 'Blot':</span>
                                      <ul style="list-style: disc;padding-left: 20px;">
                                        <li><span dir="ltr">Originating from the venous end of the  capillaries.&nbsp;&nbsp;&nbsp; *located in the compact  middle layers of the retina.</span></li>
                                     </ul>
                                    </li>
                                     <li><span dir="ltr">Flame-shaped:</span>  
                                      <ul style="list-style: disc;padding-left: 20px;">
                                        <li><span dir="ltr">Originate from the more superficial  precapillary&nbsp;&nbsp; arterioles, follow the  course of the retinal nerve fibre layer. (liner disribution)</span></li>
                                     </ul>
                                    </li>
                                  </ul>
                                     <li><span dir="ltr"><strong>Hard exudates</strong> :</span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                      <li><span dir="ltr">located  between the inner plexiform and inner nuclear layers of the retina. (OPL)</span></li>
                                      <li><span dir="ltr">They are often  distributed in a (circinate pattern).</span></li>
                                       </ul>
                                     <li><span dir="ltr"><strong>Retinal edema</strong> :</span></li>
                                     <ul>
                                      <li><span dir="ltr">Located between the outer  plexiform and inner nuclear layers. </span></li>
                                       <li><span dir="ltr">Later it may involve the inner  plexiform and nerve fibre layers, until eventually the entire thickness of the  retina may become oedematous. </span> </li>
                                       <li><span dir="ltr">With further accumulation of fluid, the fovea  assumes a cystoid appearance .</span></li>
                                    </ul>
                                     <li><span dir="ltr"><strong>Cotton-wool spots</strong>: (Soft  exudates )</span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                      <li><span dir="ltr">Nerve fiber layer infarction.</span></li>
                                     <li><span dir="ltr">Caused by capillary occlusion in the retinal nerve fibre layer.</span></li>
                                    </ul>
                                     <li><span dir="ltr"><strong>Intraretinal microvascular  abnormalities</strong> (lRMA) :</span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                      <li><span dir="ltr">Dilated, tortous retinal capillaries that  act as a shunt between arterioles and venules.</span></li>
                                     <li><span dir="ltr">Frequently  seen adjacent to areas of capillary closure.</span></li>
                                    </ul>
                                     <li><span dir="ltr">&nbsp;<strong>New Vessels:</strong></span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Unlike IRMA, they arise on the  retinal surface and may extend or be pulled into the vitreous cavity.</span></li>
                                       <li><span dir="ltr">NVD : NV appears on or within one  DD of disc margin .</span></li>
                                       <li><span dir="ltr">NVE : any other location </span></li>
                                    </ul>
                                      <li><span dir="ltr"><strong>Fibrous Glial proliferation :</strong></span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Accompained growth of new vessels.</span></li>
                                       <li><span dir="ltr">It is proliferation between the  posterior vitreous gel and the ILM.</span></li>
                                       <li><span dir="ltr">Derived from retinal glial cells  and fibrocytes</span></li>
                                    </ul>
                                    </ol>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="204" src="images/diabetic_retinopathy_clip_image001.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="204" src="images/diabetic_retinopathy_clip_image003.jpg">&nbsp;</p>
                                   <p>&nbsp;</p>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="267" src="images/diabetic_retinopathy_clip_image005.jpg">&nbsp;</p>
                                <u><h4>Types of Diabetic Retinopathy</h4></u>
                                   There are two types of diabetic retinopathy:
                                  <ol>
                                    <li><span dir="ltr"><strong>Nonproliferative diabetic retinopathy (NPDR)</strong></span></li>
                                       <ul style="list-style: circle;padding-left: 20px;">
                                          <li><span dir="ltr"><em>Mild </em>- Microaneurysms,  retinal hemorrhage and hard exudate </span></li>
                                          <li><span dir="ltr"><em>Moderate</em> - Mild NPDR plus  cotton wool spots .</span></li>
                                          <li><span dir="ltr"><em>Severe</em> - Moderate NPDR plus  one of :</span></li>
                                          <ul style="list-style: disc;padding-left: 20px;">
                                             <li><span dir="ltr">Intraretinal Hges in four  quadrants .</span></li>
                                             <li><span dir="ltr">marked venous beading in two or  more quadrants </span></li>
                                             <li><span dir="ltr">IRMA one or more quadrants</span></li>
                                        </ul>
                                     </ul>
                                       <li><span dir="ltr"><strong>Proliferative diabetic  retinopathy (PDR)-</strong></span></li>
                                       <ul style="list-style: circle;padding-left: 20px;">
                                          <li><span dir="ltr"><em>Early PDR</em> - New vessels and/or fibrous proliferations; or preretinal and/or vitreous hemorrhage</span> </li>
                                          <li><span dir="ltr"><em>PDR with HRC -NVD ≥ 1/3 of DD.</em></span></li>
                                          <ul style="list-style: disc;padding-left: 20px;">
                                             <li><span dir="ltr">less extensive NVD, if vitreous or  preretinal hemorrhage is present </span></li>
                                             <li><span dir="ltr">NVE ≥ half disc area, if vitreous  or preretinal hemorrhage is present </span></li>
                                        </ul>
                                          <li><span dir="ltr"><em>Advanced PDR </em>-Extensive  vitreous hemorrhage precluding grading.</span></li>
                                          <ul style="list-style: disc;padding-left: 20px;">
                                             <li><span dir="ltr">&nbsp;retinal detachment involving the macula.</span></li>
                                             <li><span dir="ltr">&nbsp;phthisis bulbi </span></li>
                                        </ul>
                                     </ul>
                                     </ol>
                                     <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="342" src="images/diabetic_retinopathy_clip_image007.jpg"></p>
                                     <p>&nbsp;</p>
                                     <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="412" src="images/diabetic_retinopathy_clip_image009.jpg"></p>
                                   <u><h4>Investigations</h4></u>
                                       <strong>Fluorescein Angiography</strong>
                                     <ul style="list-style: disc;padding-left: 20px;">
                                       <li><span dir="ltr">Not needed to identify CSME or  PDR.</span></li>
                                       <li><span dir="ltr">Useful because </span>
                                         <ol>
                                           <li><span dir="ltr">As a guide during CSME treatment.</span></li>
                                           <li><span dir="ltr">Identify macular capillary  nonperfusion.</span></li>
                                           <li><span dir="ltr">Identify subtle areas of NV  causing recurrent vitreous hemorrhage despite full PRP</span></li>
                                         </ol>
                                       </li>
                                     </ul>
                                     <p><strong>Optical Coherence Tomography (OCT) </strong> - In  diabetics, OCT can “map” areas of macula edema (“swelling”) thus facilitating  fluorescein angiography in guiding laser treatment of the macula.</p>
                                 <u><h4>Treatment</h4></u>
                                     <ul style="list-style: disc;padding-left: 20px;">
                                       <li><span dir="ltr"><strong>Medical Therapy </strong>:</span>
                                         <ul style="list-style: circle;padding-left: 20px;">
                                           <li><span dir="ltr">Glycemic control :</span></li>
                                           <li><span dir="ltr">Blood pressure control.</span></li>
                                           <li><span dir="ltr">Blood lipids control.</span></li>
                                         </ul>
                                       </li>
                                       <li><span dir="ltr"><strong>Laser surgery :</strong></span>
                                         <ul style="list-style: circle;padding-left: 20px;">
                                           <li><span dir="ltr">The treatment of depends on the severity of  retinopathy and t&nbsp;&nbsp; the presence or  absence of CSME, which may be present at&nbsp;  any stage .( Focal / Grid / PRP )</span></li>
                                         </ul>
                                       </li>
                                       <li><span dir="ltr"><strong>Drug therapy </strong>:</span>
                                         <ul style="list-style: circle;padding-left: 20px;">
                                           <li><span dir="ltr">Intravitreal (“inside the eye”)  drug injections:</span></li>
                                           <li><span dir="ltr">Triamcinolone (a corticosteroid; mechanism of  action unclear)</span></li>
                                           <li><span dir="ltr">Macugen, Lucentis, &amp; Avastin (drugs  primarily used to manage neovascular (“wet”) age-related macular degeneration  (reduction in the severity of retinopathy by inhibiting VEGF).</span></li>
                                         </ul>
                                       </li>
                                       <li><span dir="ltr"><strong>Vitrectomy </strong>–</span>
                                         <ul style="list-style: circle;padding-left: 20px;">
                                           <li><span dir="ltr">Indications: Vitreous hemorrhage  (clear, gel-like substance in middle of eye) fills with non-clearing blood and  traction retinal detachment.</span></li>
                                           <li><span dir="ltr">Performed in the operating room, this microsurgical  procedure</span></li>
                                           <li><span dir="ltr">Involves removing the blood-filled  vitreous and removal of</span></li>
                                           <li><span dir="ltr">Neovascular (new vessel) membranes  (fibrovascular proliferation)</span></li>
                                           <li><span dir="ltr">Improves vision by re-establishing clear  vitreous fluids and lowers</span></li>
                                           <li>T<span dir="ltr">he probability of future bleeding  by removing the neovascular membranes.</span></li>
                                           <li><span dir="ltr">Removal of scar-like (fibrovascular) membranes  results in retinal</span></li>
                                           <li>R<span dir="ltr">eattachment and possible  improvement in vision.</span></li>
                                         </ul>
                                       </li>
                                     </ul>          </td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                              <!-- <div class="pbmit-short-description">
                                 <h2>Diabetic Retinopathy</h2>
                              </div>           
                              <div class="pbmit-short-description">
       
                                  <ul style="list-style: disc;padding-left:20px;">
                                     <li>What is diabetes !! - Diabetes mellitus is the inability of the body to use and store sugar properly, resulting in high blood glucose (sugar) levels</li>
                                     <li>Diabetes results in damage to veins, arteries and capillaries throughout the body.</li>
                                     <li>Diabetes affecting vision –
                              
                                       <ul style="list-style: circle;padding-left:20px;">
                                           <li>Increases the likelihood of cataracts</li>
                                           <li>Increases the risk glaucoma</li>
                                           <li>Risk of developing diabetic retinopathy: damage occurs to the fragile blood vessels of the retina</li>     
                                        </ul>
       
                                     </li>
                                     <li>Diabetic retinopathy is a leading cause of new cases of blindness in people aged 20 to 74 years</li>
                                  </ul>
                              </div>
                              <div class="pbmit-short-description">
                                <h3>Etiology:</h3>
                                  <ul style="list-style: number;padding-left:20px;">
                                     <li>The duration of diabetes:
                           
                                       <ul style="list-style: circle;padding-left:20px;">
                                           <li>It is the most important factor.</li>
                                           <li>In patients diagnosed as having diabetes before the age of 30 years, the incidence of DR :<br/>
                                               <ul style="list-style: disc;padding-left:20px;">
                                                   <li>After 10 years is 50%</li>
                                                   <li>After 30 years is  90%</li>
                                                </ul>
                                           </li>
                                        </ul>
                                     </li>
                                     <li>Glycemic control:<br/>
                                       <ul style="list-style: circle;padding-left:20px;">
                                       <li>Increased severity of diabetic retinopathy is associated with poorer glucose control</li>
                                       </ul>
                                     </li>
                                     <li>Miscellaneous factors:<br/>
                                       <ul style="list-style: circle;padding-left:20px;">
                                           <li>Pregnancy</li>
                                           <li>Systemic Hypertension</li>
                                           <li>Renal Disease</li>
                                           <li>Anaemia.(↓Oxygen )</li>
                                           <li>Elevated Serum lipid.</li>
                                           <li>Aarotid artery occlusive disease</li>
                                           <li>Alcohol</li>
                                           <li>Obesity</li>
       
                                           </ul>
                                     </li>
                                     <li>PVD:</li>
                                     <li>High myopia</li>
                                     <li>Removal of cataract</li>
                                  </ul>
                              </div>
       
       
                           <div class="pbmit-short-description">
                               <h2>Ophthalmic Features</h2>
                            </div>
       
                            <div class="pbmit-short-description">
                           
                                 <ul style="list-style: number;padding-left:20px;">
                                    <li><h4>Microaneurysms</h4>
                                      <ul style="list-style: circle;padding-left:20px;">
                                          <li>Located in the inner nuclear layer.</li>
                                          <li>The first clinically detectable lesions.</li>
                                          <li>Small round dots .(20-200 μ)</li>
                                          <li>Mostly located near and temporal to the macula.</li>
                                          <li>When coated with blood they may be indistinguishable from dot haemorrhages.</li>
                                       </ul>
                                    </li>
                                    <li>
                                       <h4>Haemorrhages:</h4> The clinical appearance depending on location<br/>
                                      <ul style="list-style: circle;padding-left:20px;">
                                      <li>'Dot' and 'Blot':<br/>
                                       <ul style="list-style: disc;padding-left:20px;">
                                          <li>Originating from the venous end of the capillaries.    *located in the compact middle layers of the retina.</li>
                                       </ul>
                                      </li>

                                      <li>Flame-shaped:<br/>
                                       <ul style="list-style: disc;padding-left:20px;">
                                          <li>Originate from the more superficial precapillary   arterioles, follow the course of the retinal nerve fibre layer. (liner disribution)</li>
                                       </ul>
                                      </li>
                                      </ul>
                                    </li>
                                    <li><h4>Hard exudates :</h4>
                                      <ul style="list-style: circle;padding-left:20px;">
                                          <li>located between the inner plexiform and inner nuclear layers of the retina. (OPL)</li>
                                          <li>They are often distributed in a (circinate pattern).</li>       
                                          </ul>
                                    </li>
                                    <li><h4>Retinal edema :</h4>
                                       <ul style="list-style: circle;padding-left:20px;">
                                          <li>Located between the outer plexiform and inner nuclear layers.</li>
                                          <li>Later it may involve the inner plexiform and nerve fibre layers, until eventually the entire thickness of the retina may become oedematous.</li>       
                                          <li>With further accumulation of fluid, the fovea assumes a cystoid appearance .</li>
                                       </ul>
                                    </li>
                                    <li><h4>Cotton-wool spots: (Soft exudates )</h4>
                                       <ul style="list-style: circle;padding-left:20px;">
                                          <li>Nerve fiber layer infarction.</li>
                                          <li>Caused by capillary occlusion in the retinal nerve fibre layer.</li>       
                                       </ul>
                                    </li>
                                    <li><h4>Intraretinal microvascular abnormalities (lRMA) :</h4>
                                       <ul style="list-style: circle;padding-left:20px;">
                                          <li>Dilated, tortous retinal capillaries that act as a shunt between arterioles and venules.</li>
                                          <li>Frequently seen adjacent to areas of capillary closure.</li>       
                                       </ul>
                                    </li>
                                    <li><h4> New Vessels:</h4>
                                       <ul style="list-style: circle;padding-left:20px;">
                                          <li>Unlike IRMA, they arise on the retinal surface and may extend or be pulled into the vitreous cavity.</li>
                                          <li>NVD : NV appears on or within one DD of disc margin .</li>   
                                          <li>NVE : any other location</li>    
                                       </ul>
                                    </li>
                                    <li><h4>Fibrous Glial proliferation :</h4>
                                       <ul style="list-style: circle;padding-left:20px;">
                                          <li>Accompained growth of new vessels.</li>
                                          <li>It is proliferation between the posterior vitreous gel and the ILM.</li>   
                                          <li>Derived from retinal glial cells and fibrocytes</li>    
                                       </ul>
                                    </li>
                                 </ul>
                             </div>

                             <div class="pbmit-short-description">
                                 <div class="row">
                                    <div class="col-sm-6">
                                       <img src="images/retinal_detachment_clip_image002.jpg" class="img-fluid" alt="retina">
                                    </div>
                                    <div class="col-sm-6">
                                       <img src="images/hard_excudate.jpg" class="img-fluid" alt="retina">
                                    </div>
                                    <div class="col-sm-6">
                                       <img src="images/diabetic_retinopathy.jpg" class="img-fluid" alt="retina">
                                    </div>
                                 </div>
                           </div> -->
                       
                        </div>
                        </div>

                        <div class="tab-content">

                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
        <tbody><tr>
		  <td  align="left" valign="top">&nbsp;</td>
		  <td  align="left" valign="top" class="Page_title"><h2>Retinal Detachment</h2></td>
		  <td  align="left" valign="top">&nbsp;</td>
		</tr>
        <tr>
		  <td  align="left" valign="top">&nbsp;</td>
		  <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
		  <p>Retinal Detachment (R.D.)  is a separation of the sensory retina from the  retinal pigment epithelium(R.P.E) by sub retinal fluid(S.R.F)</p>
		    <p>There are two main types.</p>
		    <ol>
			  <li><span dir="ltr">Rhegmatogenous or Primary R.D.</span></li>
		      <li><span dir="ltr">Nonrhegmatous or Secondary R.D.</span></li>
			</ol>
		    <p>Secondary R.D sub divided in to two types:</p>
		    <ul style="list-style: disc;padding-left: 20px;">
		      <li><span dir="ltr">Tractional R.D.</span></li>
		      <li><span dir="ltr">&nbsp;Exudative(Serous) R.D</span></li>
	        </ul>
		    <p><strong><u><h4>Rhegmatogenous RD</h4></u></strong></p>
		    <ul style="list-style: disc;padding-left: 20px;">
		      <li><span dir="ltr">Rhegmatogenous R.D is a condition in which fluid from vitreous cavity passes through a full thickness retinal  defect in to the sub retinal space to cause separation of the neural retina  from the underlying R.P.E</span></li>
		      <li><span dir="ltr">It affects about 1:10,000 of the  population each year</span></li>
	        </ul>
		    <p><img  height="151" src="images/retinal_detachment_clip_image002.jpg"></p>
		    <p><strong><u><h4>Etiology</h4></u></strong></p>
		    <ul  style="list-style: disc;padding-left: 20px;">
		      <li><span dir="ltr">Neural retinal break</span></li>
		      <li><span dir="ltr">Vitreous liquefaction and detachment </span></li>
		      <li><span dir="ltr">Vitreoretinal traction</span></li>
		      <li><span dir="ltr">Intra ocular fluid currents  associated with&nbsp;&nbsp; movement of liquid  vitreous and sub retinal&nbsp; fluid</span></li>
		      <li><span dir="ltr">History of trauma</span></li>
		      <li><span dir="ltr">History of previous ocular disease</span></li>
		      <li><span dir="ltr">History of systemic diseases </span></li>
	        </ul>
		    <p><strong><u><h4>Ophthalmic Features</h4></u></strong></p>
		    <ul style="list-style: disc;padding-left: 20px;">
		      <li><span dir="ltr">Age: Common age group is 40-70  years</span></li>
		      <li><span dir="ltr">Sex: 60 % case comprises by males</span></li>
		      <li><span dir="ltr">Hereditary: although a no.of  pedigree shows familial detachments, most cases are sporadi</span></li>
		      <li><span dir="ltr">Common complains -</span></li>
		      <li><span dir="ltr">Flashes of lights(Photopsia)</span></li>
		      <li><span dir="ltr">Floaters- may be </span></li>
		      <li><span dir="ltr">Solitary ring shaped  opacity(Weiss Ring) </span></li>
		      <li><span dir="ltr">Cobwebs </span></li>
		      <li><span dir="ltr">Sudden shower of minute red  colored or dark spots</span></li>
		      <li><span dir="ltr">Localized relative loss in field  of vision</span></li>
		      <li><span dir="ltr">sudden painless loss of vision </span></li>
		      <li><span dir="ltr">Blurring of distant vision</span></li>
		      <li><span dir="ltr">Pupil – RAPD</span></li>
		      <li><span dir="ltr">Fundus Examination – Loss of  normal fundal glow</span></li>
		      <li><span dir="ltr">Retinal breaks:</span></li>
		      <li><span dir="ltr">Present in about 70% of </span></li>
		      <li><span dir="ltr">The eyes with tobacco dust.</span></li>
		      <li><span dir="ltr">appears as red discontinuities in  the retinal surface</span></li>
		      <li><span dir="ltr">Upper temporal quadrant is the  commonest site for retinal break </span></li>
	        </ul>
		    <p><img  height="188" src="images/retinal_detachment_clip_image004.jpg" alt="C:\My Documents\rd.Rt.jpg"> <img  height="188" src="images/retinal_detachment_clip_image006.jpg" alt="C:\WINDOWS\Desktop\TEAR.jpg"></p>
		    
		    <p><img  height="342" src="images/retinal_detachment_clip_image008.jpg" alt="C:\My Documents\rd.Rt001.jpg"><br>
                <strong>Shape of R.D in relation to primary break</strong></p>
		    
		    <p>Retinal signs depends on  duration of R.D.</p>
		    <ol>
		      <li><span dir="ltr">Fresh R.D</span></li>
		    	<ul style="list-style: circle;padding-left: 20px;">
				  <li><span dir="ltr">Detached retina has a convex  configuration,slightly opaque and corrugated appearance, undulates freely with  eye movements</span></li>
				</ul>
		      <li><span dir="ltr">Long standing retinal detachment</span></li>
		    	<ul style="list-style: circle;padding-left: 20px;">
				  <li><span dir="ltr">Retinal thinning secondary to atrophy,  secondary intraretinal cysts if more than 1 year,&nbsp; sub retinal&nbsp;  demarcation lines, present after 3 months.</span></li>
				</ul>
	        </ol>
		    <p><strong><h4><u>Treatment</u></h4></strong></p>
		    <ol>
		      <li><span dir="ltr">Cryotherapy</span></li>
		      <li><span dir="ltr">Scleral Buckling</span></li>
		      <li><span dir="ltr">Pneumatic Retinopexy</span></li>
		      <li><span dir="ltr">Vitrectomy</span></li>
		    </ol>
		    <ol>
		      <li><span dir="ltr"><strong>Cryo therapy</strong></span></li>
		    	<ul style="list-style: circle;padding-left: 20px;">
				  <li><span dir="ltr">Cryotherapy (freezing) or laser photocoagulation&nbsp; are occasionally used alone to wall off a  small area of retinal detachment so that the detachment does not spread.</span></li>
				</ul>
		      <li><span dir="ltr"><strong>Scleral Buckle surgery</strong></span></li>
		    	<ul style="list-style: circle;padding-left: 20px;">
				  <li><span dir="ltr">Scleral buckle surgery is an established treatment in which the eye surgeon sews one or  more silicone bands (bands, tyres) to the sclera (the white outer coat of the  eyeball). The bands push the wall of the eye inward against the retinal hole,  closing the break or reducing fluid flow through it and reducing the effect of  vitreous traction thereby allowing the retina to re-attach. Cryotherapy  (freezing) is applied around retinal breaks prior to placing the buckle. Often  subretinal fluid is drained as part of the buckling procedure. The buckle  remains in situ. The most common side effect of a scleral operation is myopic  shift.</span></li>
				</ul>
		      <li><span dir="ltr"><strong>Pneumatic retinopexy</strong></span></li>
		    	<ul style="list-style: circle;padding-left: 20px;">
				  <li><span dir="ltr">This operation is  generally performed in the doctor's office under local anesthesia. It is  another method of repairing a retinal detachment in which a gas bubble (SF6 or  C3F8 gas) is injected into the eye after which laser or freezing treatment is  applied to the retinal hole. The patient's head is then positioned so that the  bubble rests against the retinal hole. Patients may have to keep their heads  tilted for several days to keep the gas bubble in contact with the retinal  hole. The surface tension of the air/water interface seals the hole in the  retina, and allows the retinal pigment epithelium to pump the subretinal space  dry and suck the retina back into place. This strict positioning requirement  makes the treatment of the retinal holes and detachments that occurs in the  lower part of the eyeball impractical. This procedure is usually combined with  cryopexy or laser photocoagulation.</span></li>
				</ul>
	          <li><span dir="ltr"><strong>Vitrectomy</strong>
		    	<ul style="list-style: circle;padding-left: 20px;">
				  <li><span dir="ltr">Vitrectomy is an increasingly used treatment for retinal detachment. It  involves the removal of the vitreous gel and is usually combined with filling  the eye with either a gas bubble (SF6 or C3F8 gas) or silicon oil. An advantage of using gas in this operation is that there  is no myopic shift after the operation and gas is absorbed within a few weeks.  Silicon oil (PDMS), if filled needs to be removed after a period of 2–8 months  depending on surgeon's preference. Silicon oil is more commonly used in cases  associated with proliferative vitreo-retinopathy (PVR). A disadvantage is that  a vitrectomy always leads to more rapid progression of a cataract in the  operated eye. In many places vitrectomy is the most commonly performed  operation for the treatment of retinal detachment.</span></li>
				</ul>
 	        </span></li></ol>
		  </td>
		  <td  align="left" valign="top">&nbsp;</td>
		</tr>
        <tr>
		  <td colspan="3" align="left" valign="top">&nbsp;</td>
		</tr>
        <tr>
		  <td colspan="3" align="center">&nbsp;</td>
		</tr>
	  </tbody></table>


                           </div>
                        </div>

                        <div class="tab-content">
                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><h2>AMD</h2></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                 <ul style="list-style: disc;padding-left: 20px;">
                                   <li><span dir="ltr">A layer of the retina called the  retinal pigment epithelium (RPE) is disrupted by deposits called <em>drusen</em>,  or other age-related changes. These changes, if severe enough, may cause vision  to deteriorate. When the macula breaks down, you lose your central vision, but  it does not affect your peripheral (side) vision.</span></li>
                                   <li><span dir="ltr">A leading cause of severe vision  loss in people over 65 years of age ,associated with the aging process; the  macula may lose effectiveness over time.</span></li>
                                   </ul>
                                   <p><strong><u><h4>Ophthalmic Features</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Early AMD may be hardly  noticeable, and may only occur in one eye.</span></li>
                                     <li><span dir="ltr">Words on a page may look blurred.</span></li>
                                     <li><span dir="ltr">It may be difficult to recognize people’s  faces.</span></li>
                                      <li> A dark or  empty area may appear in the center of vision.</li>
                                     <li><span dir="ltr">Straight lines may look distorted.</span></li>
                                     <li><span dir="ltr">With AMD, dark areas may appear in  your central vision</span></li>
                                   </ul>
                                   <p><strong><u><h4>Two types of AMD</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr"><strong>Atrophic (Dry) AMD </strong>- Caused  by aging and thinning of macular tissues when drusen are present.</span>
                                       <ul style="list-style: circle;padding-left: 20px;">
                                         <li><span dir="ltr">Vision loss is usually gradual.</span></li>
                                         <li><span dir="ltr">Most common form.</span></li>
                                        </ul>
                                     </li>
                                     
                                     <li><span dir="ltr"><strong>Exudative (Wet) AMD</strong> - Caused  when abnormal</span>
                                       <ul style="list-style: circle;padding-left: 20px;">
                                         <li><span dir="ltr">Blood vessels form underneath the  retina. These vessels leak&nbsp; blood/fluid  and blur central vision.</span></li>
                                         <li><span dir="ltr">Vision loss may be rapid and severe. </span></li>
                                        </ul>
                                     </li>
                                   </ul>
                                   <p><img  height="188" src="images/amd_clip_image002.jpg"><img width="204" height="188" src="images/amd_clip_image004.jpg"><img  height="188" src="images/amd_clip_image006.jpg"></p>
           
                                   <p><strong><u><h4>Investigations</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Many people do not realize they  have a problem until vision blurs.</span></li>
                                     <li><span dir="ltr">Your ophthalmologist can detect early AMD&nbsp; during an eye exam that includes:</span></li>
                                     <li><span dir="ltr"><strong>Ophthalmoscopic examination</strong></span>
                                       <ul style="list-style: circle;padding-left: 20px;">
                                         <li>Fluorescein angiography - Dye is  injected into your arm where it travels through the body to the blood vessels  in your eye.</li>
                                         <li><span dir="ltr">Special photographs are taken of  your eye; dye will highlight abnormal blood vessel growth under the retina</span></li>
                                        </ul>
                                     </li>
                                    </ul>
                                   <p><img  height="144" src="images/amd_clip_image008.jpg"></p>
                                   <p><strong><u><h4>Make most of your vision</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">If you have been diagnosed with  AMD, you must monitor your vision every day with an Amsler Grid.</span></li>
                                     <li><span dir="ltr">With AMD, Amsler Grid may contain  blurry or wavy lines.</span></li>
                                     <li><span dir="ltr">Preserve good vision with regular  eye exams</span></li>
                                    </ul>
                                   <p><img  height="170" src="images/amd_clip_image010.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="170" src="images/amd_clip_image012.jpg"><br>
                                         <span class="style3"><strong>Amsler  Grid, as seen through a normal eye&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  Amsler Grid, as might be seen through an eye with AMD</strong></span></p>
                                   <p><strong><u><h4>Treatment (Dry AMD)</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">There is no treatment for dry AMD.</span></li>
                                     <li><span dir="ltr">Nutritional supplements may help  slow progression and impact of AMD:</span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Vitamins C, E</span></li>
                                       <li><span dir="ltr">Beta carotene</span></li>
                                       <li><span dir="ltr">Zinc </span></li>
                                      </ul>
                                    </ul>
                                   <p>(Vitamin supplements are not cures for AMD, nor can they  restore vision already lost from AMD.)</p>
                                   <p><img  height="156" src="images/amd_clip_image014.jpg"></p>
                                   <p><strong><u><h4>Treatment (Wet AMD)</h4></u></strong></p>
                                     <ol>
                                       <li><span dir="ltr"><strong>Thermal Laser Therapy</strong> - Used when abnormal blood  vessel growth is not under center of macula. High-energy, focused light beam  treats tiny area of retina by “burning” it; destroys abnormal underlying blood vessels, preventing further leakage/bleeding/growth</span></li>
                                   <ul style="list-style: circle;padding-left: 20px;">
                                     <li><span dir="ltr">Following treatment, your vision  may be more blurred than before; will stabilize within a few weeks.</span></li>
                                     <li><span dir="ltr">Scar forms where treatment  occurred, creating a permanent blind spot that might be noticeable in your  field of vision.</span></li>
                                     <li><span dir="ltr">Likely that 50% of wet AMD  patients who have laser procedure will need re-treatment within 3 to 5 years..</span></li>
                                    </ul>
                                       <li><span dir="ltr"><strong>Photo Dynamic Therapy (PDT)</strong> - If abnormal blood  vessels grow under center of macula, PDT may be a treatment option. Uses a  combination of a light-activated (photo- sensitive) drug and a special  low-power (cool) laser.</span></li>
                                   <ul style="list-style: circle;padding-left: 20px;">
                                     <li><span dir="ltr">Photosensitive drug injected into  vein in arm, where it travels throughout the body; attaches to molecules found  in abnormal blood vessels. Laser light targeted directly on the abnormal  vessels, activating the drug; drug causes damage specifically to those unwanted  blood vessels. After PDT, abnormal blood vessels may re-open; multiple  treatments may be required.</span></li>
                                    </ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr"><strong>Anti-VEGF treatment</strong> - A certain chemical in  your&nbsp;&nbsp; body is critical in causing  abnormal blood vessels to grow&nbsp; under the  retina, and is called vascular endothelial growth factor, or VEGF. There are several  drugs (anti-VEGF) that can block the trouble-causing VEGF. Blocking VEGF  reduces the growth of abnormal blood vessels, slows their leakage, and helps to  slow vision loss.</span></li>
                                   <ul style="list-style: circle;padding-left: 20px;">
                                     <li><span dir="ltr">The anti-VEGF drug is injected  into your eye with a very fine needle.(Your ophthalmologist will clean your eye  to prevent infection and will administer an anesthetic eye drops to your eye to  prevent pain.) </span></li>
                                     <li><span dir="ltr">Patients receive multiple  anti-VEGF injections over the course of many months.</span></li>
                                     <li><span dir="ltr">In some cases, your  ophthalmologist may recommend combining anti-VEGF treatment with other  therapies (i.e. some patients also receive photodynamic laser therapy).</span></li>
                                    </ul>
                                  </ol>
                                   <p><strong><u><h4>What happens when AMD cannot be treated?</h4></u></strong></p>
                                   <ul>
                                     <li><span dir="ltr">People with wet or dry AMD who  cannot be treated will not become blind—they will still have peripheral (side)  vision. </span></li>
                                    </ul>
                                   <ul>
                                     <li><span dir="ltr">With special low-vision  rehabilitation, devices and services, people can often learn how to “see” again  with remaining vision.</span></li>
                                    </ul>
                                   <p><strong><u><h4>Vision Rehabilitation</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Learn new strategies to accomplish  daily activities, Skills/devices/techniques help people with advanced AMD  regain confidence and live independently despite loss of central vision. </span></li>
                                     <li><span dir="ltr">Low Vision Aids- Optical  low-vision devices use lenses to magnify objects:</span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Magnifying spectacles</span></li>
                                       <li><span dir="ltr">Hand magnifiers</span></li>
                                       <li><span dir="ltr">Stand magnifiers</span></li>
                                       <li><span dir="ltr">Video magnifiers</span></li>
                                       <li><span dir="ltr">Telescopes</span></li>
                                       <li><span dir="ltr">Large-print books, newspapers,  magazines, playing cards, checks</span></li>
                                       <li><span dir="ltr">Writing/signing guides</span></li>
                                       <li><span dir="ltr">High contrast/large number  telephones, thermostats, watches, remotes</span></li>
                                     <li><span dir="ltr">Talking books, watches, timers, medical devices</span></li>
                                      </ul>
                                    </ul>
                                  </td>
                             
                               </tr>


                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <div class="about-left-section">
                            
                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><h2>BRANCH RETINAL VEIN OCCLUSION (BRVO)</h2></td>
                             
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">The clinical picture of branch retinal vein occlusion is retinal  hemorrhages that are segmental in distribution. </span></li>
                                      <li><span dir="ltr">The apex of the obstructed tributary vein almost always lies at an  arteriovenous crossing. Usually some degree of pathologic arteriovenous nicking  is present.</span></li>
                                      <li><span dir="ltr">The occlusion is commonly located one or two disc diameters away from  the optic disc. However, the occlusion may lie at a point near the disc edge  or, less frequently, may involve one of the smaller, more peripheral tertiary  or macular branches. </span></li>
                                   </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="156" src="images/brvo_clip_image002.jpg"></p>
                                   <p><strong><u><h2>Etiology</h2></u></strong></p>
                                   <ul  style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Systemic Hypertension</span></li>
                                     <li><span dir="ltr">History of cardio vascular disease</span></li>
                                     <li><span dir="ltr">Increased cholesterol</span></li>
                                     <li><span dir="ltr">History of glaucoma</span></li>
                                     <li><span dir="ltr">High serum levels of a2 globulin</span></li>
                                    </ul>
                                   <p><strong><u><h2>Ophthalmic Features</h2></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">The clinical picture of branch retinal vein occlusion is <strong>retinal  hemorrhages</strong> that are segmental in distribution. </span></li>
                                     <li><span dir="ltr">The apex of the obstructed tributary vein almost always lies at an  arteriovenous crossing. Usually some degree of pathologic arteriovenous nicking  is present.</span></li>
                                     <li><span dir="ltr">The occlusion is commonly located one or two disc diameters away from  the optic disc. However, the occlusion may lie at a point near the disc edge  or, less frequently, may involve one of the smaller, more peripheral tertiary  or macular branches</span></li>
                                    </ul>
                                   <p><img  height="188" src="images/brvo_clip_image004.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="188" src="images/brvo_clip_image006.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="188" src="images/brvo_clip_image008.jpg"></p>
                                   <p><strong><u><h2>Treatment</h2></u></strong></p>
                                   <ol>
                                     <li><span dir="ltr"><strong>Medical treatment</strong> of  branch retinal vein occlusion (BRVO) is not effective. In the past, anticoagulants,  fibrinolytic agents, clofibrate capsules (Atromid-S), and carbogen inhalation  have been used but without success.</span></li>
                                     <li><span dir="ltr"><strong>Intravitreal injection of  Bevacizumab- </strong>Bevacizumab is a humanized recombinant monoclonal IgG antibody  that binds and inhibits all VEGF isoforms. Several small retrospective and  uncontrolled case series suggest that intravitreal bevacizumab at doses up to  2.5 mg are effective in improving visual acuity and reducing central macula  thickness in eyes with macular edema secondary to BRVO. These results are often  seen within 1 month of injection. However, most of the eyes will require  additional injections to maintain the effects of bevacizumab.</span></li>
                                     <li><span dir="ltr"><strong>Intravitreal injection of  Ranibizumab</strong>- A multicenter, prospective, phase III trial comparing intravitreal  ranibizumab and sham injections demonstrated the value of VEGF inhibition in  eyes with macular edema secondary to BRVO. In this study, eyes were randomized  to monthly sham injections, 0.3 mg of ranibizumab and 0.5 mg of ranibizumab,  for the first 6 months. Eyes were eligible for rescue laser at month 3 if the  hemorrhages had sufficiently cleared to allow safe treatment and if the visual  acuity remained at 20/40 or less and the central macular thickness was 250 µm  or less.</span></li>
                                     <li><span dir="ltr"><strong>Intravitreal injection  of&nbsp; Triamcinolone </strong>- Intravitreal  injection of triamcinolone has been used to treat macular edema of different  etiologies because of its potent antipermeability and anti-inflammatory  properties. A few cases of macular edema secondary to BRVO treated with an  intravitreal triamcinolone injection have been reported. The exact dose remains  unclear. Doses from 4 mg to 25 mg have been reported to be effective. </span></li>
                                     <li><span dir="ltr"><strong>Macular grid laser  photocoagulation- </strong>Macular grid laser photocoagulation remains the criterion  standard treatment of eyes with perfused macular edema secondary to BRVO</span></li>
                                     <li><span dir="ltr"><strong>Vitrectomy &amp;  arteriovenous decompression </strong>- Several surgeons have reported resolution of  macular edema secondary to BRVO after vitrectomy with or without peeling of the  internal limiting membrane. </span></li>
                                      <ul style="list-style: circle;padding-left: 20px;">
                                        <li><span dir="ltr">Vitrectomy and posterior hyaloid  separation improved the visual acuity in eyes with macular edema secondary to  BRVO. </span></li>
                                     </ul>
                                    </ol>
                                  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="156" src="images/brvo_clip_image010.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="156" src="images/brvo_clip_image012.jpg"></p></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">


                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><h2>CENTRAL RETINAL VEIN OCCLUSION (CRVO)</h2></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                 <p>The  actual mechanisms producing the clinical picture of central retinal vein  occlusion may be roughly divided into those conditions that produce a physical  blockage at the level of the lamina cribrosa, and those conditions in which  hemodynamic factors result in an obstruction to the flow of blood. These  mechanisms probably coexist in many patients with Central Vein Occlusion.</p>
                                     <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="156" src="images/crvo_clip_image002.jpg"></p>
                                   <p><strong><u><h4>Etiology</h4></u></strong></p>
                                   <ul>
                                     <li><span dir="ltr">An increased risk of central retinal vein occlusion was found in  patients with systemic hypertension, diabetes mellitus, and open-angle  glaucoma; the risk of central vein occlusion was decreased for patients with  increasing levels of physical activity and increasing levels of alcohol  consumption. </span></li>
                                     <li><span dir="ltr">For women, the risk decreased with the use of postmenopausal estrogen  and increased with a higher erythrocyte sedimentation rate. </span></li>
                                    </ul>
                                   <p><strong><u><h4>Two types of CRVO</h4></u></strong></p>
                                   <ul>
                                     <li><span dir="ltr"><strong>Ischemic CRVO</strong> - Patients with an ischemic pattern are usually aware of a sudden, painless decrease in  visual acuity. Vision ranges from 20/400 to hand movements. </span></li>
                                      <ul>
                                        <li><span dir="ltr">The onset, however, is generally not as rapid or the visual loss as  extensive as in central retinal artery occlusion. </span></li>
                                        <li><span dir="ltr">Exceptional cases have been noted in which patients with an acute onset  had reasonably good vision and yet demonstrated a picture of ischemic central  retinal vein occlusion. </span></li>
                                     </ul>
                                     <li><span dir="ltr"><strong>Non Ischemic CRVO</strong> - Nonischemic central retinal vein  occlusion is a much milder and more variable disease in appearance, symptoms,  and course compared with ischemic central retinal vein occlusion</span></li>
                                    </ul>
                                   <p><strong><u><h4>Ophthalmic Features </h4></u></strong></p>
                                     <p><strong>Confluent  hemorrhages </strong>are the  most prominent ophthalmoscopic feature of an acute ischemic central retinal  vein occlusion These hemorrhages occur in a wide variety of shapes and sizes;  they are usually concentrated in the posterior pole, but may be seen throughout  the retina. Many hemorrhages are flame shaped, reflecting the orientation of  the nerve fibers. Dot and punctate hemorrhages are interspersed and indicate  involvement of the deeper retinal layers. Bleeding may be extensive, erupting  through the internal limiting membrane to form a preretinal hemorrhage or  extending into the vitreous. Small dot hemorrhages may be seen either isolated  or clustered around small venules. The entire venous tree is tortuous,  engorged, dilated, and dark. The retina is edematous, particularly in the  posterior pole; some of this edema may obscure portions of the retinal vessels. Cotton-wool patches (soft exudates) are often present.</p>
                                   <p>The <strong>disc  margin is blurred or obscured</strong>, and the precapillary arterioles appear  engorged. Splinter hemorrhages and edema are present on the disc surface and  extend into the surrounding retina. The physiologic cup is filled, and the  venous pulse is absent. The arterioles, often overlooked because of the other  more striking pathologic features, are frequently narrowed. Sometimes in  central retinal vein occlusion of acute onset, the fundus picture is less  dramatic, and all of the findings previously discussed may be present, but to a  lesser degree. Vision depends on extent of macular involvement</p>
                                   <p>&nbsp;</p>
                                   <p><img  height="192" src="images/crvo_clip_image003.jpg">&nbsp;&nbsp;&nbsp;&nbsp;<img  height="192" src="images/crvo_clip_image004.jpg">&nbsp;&nbsp;&nbsp;&nbsp;<img  height="192" src="images/crvo_clip_image005.jpg"></p>
                                   <p><strong>&nbsp;</strong></p>
                                   <p><strong><u><h4>Investigations</h4></u></strong></p>
                                   <ul>
                                     <li><span dir="ltr">All patients with central retinal vein occlusion should have a  comprehensive ophthalmic evaluation, including an appropriate evaluation for glaucoma.  In addition, they should be referred to their primary care physician for an  evaluation of cardiovascular risk factors, including hypertension and diabetes</span></li>
                                     <li><span dir="ltr">Standard investigations-</span>FBC, PV, ESR</li>
                                     <li><span dir="ltr">U+E, Creatinine</span></li>
                                     <li><span dir="ltr">LFT, Protein Electrophoreseis</span></li>
                                     <li><span dir="ltr">Random Glucose, Lipid</span></li>
                                     <li><span dir="ltr">Urine analysis</span></li>
                                     <li><span dir="ltr">Ophthalmic investigations – FFA, Colour Doppler </span></li>
                                    </ul>
                                   <p><strong><u><h4>FFA</h4></u></strong></p>
                                   <ul>
                                     <li><span dir="ltr">The intravenous fluorescein angiogram pattern of an ischemic central  retinal vein occlusion is usually characterized by a delayed filling time of  the venous tree of the retina, capillary and venous dilation, and extensive  leaking of fluorescein into the retina, particularly in the macular area and in  the area adjacent to the larger venous trunks and capillary nonperfusion may  not be noted at the time of initial occlusion, but are usually manifest shortly  thereafter. Late-phase photographs show patchy extravascular areas of  fluorescence and staining of the retinal veins. </span></li>
                                     <li><span dir="ltr">Microaneurysms may not be noted at the time of initial occlusion, but  are usually manifest shortly thereafter. </span></li>
                                     <li><span dir="ltr">Late-phase photographs show patchy extravascular areas of fluorescence  and staining of the retinal veins. Fluorescence in the macula indicates  capillary leakage and edema; this not only may account for much of the initial  visual loss in the acute phase, but may eventually result in permanent  structural changes. </span></li>
                                     <li><span dir="ltr">Fluorescence in the macula indicates capillary leakage and edema; this  not only may account for much of the initial visual loss in the acute phase,  but may eventually result in permanent structural changes</span></li>
                                     <li><span dir="ltr">The most serious complication of central retinal vein occlusion is  neovascularization. </span></li>
                                     <li><span dir="ltr">Neovascularization elsewhere (NVE) occurs less frequently than  neovascularization of the iris (NVI), and usually only in ischemic occlusions.</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="200" src="images/crvo_clip_image006.jpg"></p>
                                   <p><strong><u><h4>Treatment</h4></u></strong></p>
                                   <ol>
                                     <li><span dir="ltr">Medical management- No known  effective medical treatment is available for either the prevention of or the  treatment of central retinal vein occlusion (CRVO). Identifying and treating  any systemic medical problems to reduce further complications is important.  Because the exact pathogenesis of the CRVO is not known, various medical  modalities of treatment have been advocated by multiple authors with varying  success in preventing complications and in preserving vision.</span></li>
                                     <li><span dir="ltr"><strong>Intravitreal Bevacizumab- </strong>In  patients with macular edema, injection of bevacizumab (0.05 mL/1.25 mg) into  the vitreous cavity through pars plana has been shown to be effective not only  in resolving the edema but also in corresponding improvement in vision.</span></li>
                                      <ul>
                                        <li><span dir="ltr">Also, in patients with neovascular  glaucoma, a similar dose has shown significantly decreased angle  neovascularization and improved intraocular pressure control, both medically  and surgically.</span></li>
                                        <li><span dir="ltr">Even though the exact mechanism of  action of intravitreal injections of bevacizumab is not known, bevacizumab  probably reduces VEGF concentrations in the vitreous cavity. This leads to a  reduction in capillary permeability and macular edema. The main drawback of  these injections is post treatment recurrences of macular edema, requiring  repeat injections.</span></li>
                                        <li><span dir="ltr">Significant complications reported  due to the injection of bevacizumab include cataract, glaucoma, retinal  detachment, vitreous hemorrhage, and endophthalmitis</span></li>
                                     </ul>
                                     <li><span dir="ltr"><strong>Intravitreal injection of ranibizumab -</strong></span></li>
                                      <ul>
                                        <li><span dir="ltr">Vascular endothelial growth factor  (VEGF) expression is upregulated by hypoxia and was noted to be elevated in the  ocular fluids of patients with CRVO. One of the potent effects of VEGF is to  increase vascular permeability in the macula leading to visually significant  macular edema. </span></li>
                                        <li><span dir="ltr">Ranibizumab is a humanized,  affinity-matured VEGF antibody fragment that binds to and neutralizes all  isoforms of VEGF. Ranibizumab showed improved visual outcomes in patients with  neovascular age-related vascular degeneration due to its anti-VEGF activity.  The role of ranibizumab in the management of CRVO was reported in multiple  studies. Intraocular injections of 0.3 mg or 0.5 mg ranibizumab provided rapid  improvement in 6-month visual acuity and macular edema following CRVO, with low  rates of ocular and nonocular safety events.Long-term follow-up of these  patients is needed to know the persistence of these gains for more than 6  months.</span></li>
                                      </ul>
                                     <li><span dir="ltr">4)<strong> Dexamethasone intravitreal  implant</strong></span></li>
                                      <ul>
                                        <li><span dir="ltr">Dexamethasone is a potent,  water-soluble corticosteroid that can be delivered to the vitreous cavity by  the dexamethasone intravitreal implant (DEX implant; OZURDEX, Allergan; Irvine, Calif).  A DEX implant is composed of a biodegradable copolymer of lactic acid and  glycolic acid containing micronized dexamethasone. The drug-copolymer complex  gradually releases the total dose of dexamethasone over a series of months  after insertion into the eye through a small pars plana puncture using a  customized applicator system.</span></li>
                                      </ul>
                                   <p><img  height="136" src="images/crvo_clip_image008.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="138" src="images/crvo_clip_image010.jpg"></p>
                                   <li><span dir="ltr"><strong> Intravitreal injection of  triamcinolone</strong></span></li>
                                     <ul>
                                      <li><span dir="ltr">In patients with macular edema,  injection of triamcinolone (0.1 mL/4 mg) into the vitreous cavity through pars  plana has been shown to be effective not only in resolving the edema but also  in corresponding improvement in vision.</span></li>
                                       <li><span dir="ltr">Even though the exact mechanism of  action of intravitreal injections of corticosteroids is not known, the  triamcinolone crystals in the vitreous cavity probably reduce VEGF  concentrations in the vitreous cavity. This leads to a reduction in capillary  permeability and macular edema. The main drawback of an injection of  triamcinolone was post treatment recurrences of macular edema, requiring repeat  triamcinolone injections, typically every 3-6 months.</span></li>
                                       <li><span dir="ltr">In addition, significant complications  reported due to the injection of triamcinolone include cataract, glaucoma,  retinal detachment, vitreous hemorrhage, and endophthalmitis. </span></li>
                                    </ul>
                                     <li><span dir="ltr"><strong> Laser photocoagulation-</strong></span></li>
                                      <ul>
                                        <li><span dir="ltr">Laser photocoagulation is the  known treatment of choice in the treatment of various complications associated  with retinal vascular diseases (eg, diabetic retinopathy, branch retinal vein  occlusion). Panretinal photocoagulation (PRP) has been used in the treatment of  neovascular complications of CRVO for a long time. However, no definite  guidelines exist regarding exact indication and timing of PRP</span></li>
                                        <li><span dir="ltr">Argon green laser usually is used.  Laser parameters should be about 500-µm size, 0.1-0.2 second duration, and  power should be sufficient to give medium white burns. Laser spots are applied  around the posterior pole, extending anterior to equator. They should be about  1 burn apart and total 1200-2500 spots. </span></li>
                                        <li><span dir="ltr">If ocular media is hazy for laser  to be applied, cryoablation of the peripheral fundus is performed. About 16-32  transscleral cryo spots are applied from ora serrata posteriorly</span></li>
                                       </ul>
                                  </ol>
                                  </td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><strong><h2>CENTRAL  RETINAL ARTERY OCCLUSION (CRAO)</h2></strong></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                   <ul style="list-style: disc;padding-left:20px">
                                  <li><span dir="ltr"><strong>Epidemiology - </strong></span></li>
                                    <ul  style="list-style: circle;padding-left:20px">
                                      <li><span dir="ltr">Men &gt; Women</span></li>
                                      <li><span dir="ltr">Bilateral in 1 – 2 %</span></li>
                                      <li><span dir="ltr">&nbsp;May have other retinal vascular disease</span></li>
                                    </ul>
                                   <li><span dir="ltr"><strong>History- </strong></span></li>
                                    <ul  style="list-style: circle;padding-left:20px">
                                      <li><span dir="ltr">&nbsp;Occurs over period of seconds</span></li>
                                      <li><span dir="ltr">&nbsp;May have prior history of amaurosis fugax</span></li>
                                      <li><span dir="ltr">Painless</span></li>
                                      <li><span dir="ltr">Sudden loss of vision</span></li>
                                    </ul>
                                   </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="134" src="images/crao_clip_image002.jpg"></p>
                                   <p><strong><u><h4>Etiology</h4> </u></strong></p>
                                   <ul  style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">Systemic Hypertension 66%</span></li>
                                     <li><span dir="ltr">&nbsp;Diabetes mellitus 25%</span></li>
                                     <li><span dir="ltr">&nbsp;Cardiac valve disease 25%</span></li>
                                     <li><span dir="ltr">&nbsp;Carotid atherosclerosis 45%</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="143" src="images/crao_clip_image004.jpg"></p>
                                     <p><strong><u><h4>Ophthalmic Features</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">Vision CF to Light Perception  (90%)</span></li>
                                     <li><span dir="ltr">Rarely No Light Perception</span></li>
                                     <li><span dir="ltr">Afferent pupillary defect</span></li>
                                     <li><span dir="ltr">Cherry Red Spot- Opacification of  ganglion cells around fovea, takes hours to develop and fades in 4-6 weeks. May  be “brown” in blacks.</span></li>
                                     <li><span dir="ltr">Both arteries &amp; veins gets  thinned.</span></li>
                                     <li><span dir="ltr">May develop rubeosis &amp;  glaucoma within 1 month</span></li>
                                     <li><span dir="ltr">Occurs in up to 15-20%</span></li>
                                     <li><span dir="ltr">&nbsp;Retinal neovascularization occurs but rarely</span></li>
                                     <li><span dir="ltr">&nbsp;Ipsilateral carotid obstruction</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="136" src="images/crao_clip_image006.jpg"></p>
                                   <p><strong><u><h4>Ophthalmic Features</h4></u></strong></p>
                                   <ul  style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">Fundus Fluorescein Angiography  (FFA)</span></li>
                                     <li><span dir="ltr">Electro Retinogram (ERG)</span></li>
                                     <li><span dir="ltr">Visual fields</span></li>
                                    </ul>
                                   <p><strong><u><h4>FFA</h4></u></strong></p>
                                   <ul  style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">Delayed A-V transit time</span></li>
                                     <li><span dir="ltr">Staining of optic nerve or point  of embolus</span></li>
                                     <li><span dir="ltr">&nbsp;&nbsp;&nbsp;&nbsp;Rare retinal vessel staining</span></li>
                                     <li><span dir="ltr">Normal choroidal pattern</span></li>
                                     <li><span dir="ltr">Complete lack of filling, rare in  only 2%</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="161" src="images/crao_clip_image008.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="254" src="images/crao_clip_image010.jpg"></p>
                                   <p><strong><u><h4>ERG</h4></u></strong></p>
                                   <ul  style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">B-wave origin is inner retina,  thus CRAO gives, B wave reduction.</span></li>
                                     <li><span dir="ltr">&nbsp;A-wave is normal, since photoreceptors  perfused</span></li>
                                     <li><span dir="ltr">Compare with flat ERG seen in  ophthalmic artery occlusion</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="222" src="images/crao_clip_image012.jpg"></p>
                                   <p><strong><u><h4>Visual fields</h4></u></strong></p>
                                   <ul  style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">Often have a preserved temporal  island</span></li>
                                     <li><span dir="ltr">Spared islands corresponding to  cilioretinal sparring</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="192" src="images/crao_clip_image014.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="152" src="images/crao_clip_image016.jpg"></p>
                                   <p><strong><u><h4>Treatment</h4></u></strong></p>
                                   <ul  style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">Digital massage to dislodge  embolus</span></li>
                                     <li><span dir="ltr">A/C Paracentesis</span></li>
                                     <li><span dir="ltr">&nbsp;IV acetazolamide</span></li>
                                     <li><span dir="ltr">&nbsp;Gas Inhalation: Carbogen, Oxygen</span></li>
                                     <li><span dir="ltr">&nbsp;Retrobulbar vasodilators</span></li>
                                     <li><span dir="ltr">&nbsp;Inject Fibrinolytic in supraorbital artery</span></li>
                                     <li><span dir="ltr">&nbsp;Emergent TPPV with/without PFCL</span></li>
                                     <li><span dir="ltr">&nbsp;YAG laser embolysis</span></li>
                                    </ul>
                                  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="149" src="images/crao_clip_image018.jpg"></p></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
        
                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><strong><h2>CENTRAL SEROUS RETINOPATHY (CSR)</h2></strong></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;"><p>&nbsp;</p>
                                   <ul style="list-style: disc;padding-left: 20px;"><li><span dir="ltr">A Chorioretinal disorder  characterized by an idiopathic localized serous detachment of the neural retina  in the macular region.</span></li>
                                   <li><span dir="ltr">Usually unilateral</span></li>
                                   </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="170" src="images/csr_clip_image002.jpg"></p>
                                   <p><strong><u><h4>Etiology</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Age: 20 – 50 years</span></li>
                                     <li><span dir="ltr">Gender: Male &gt; female</span></li>
                                     <li><span dir="ltr">Increased incidence in:</span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Emotional stress</span></li>
                                       <li><span dir="ltr">Type A personality</span></li>
                                       <li><span dir="ltr">Physical Strains</span></li>
                                       <li><span dir="ltr">People engaged in visually  demanding work</span></li>
                                       <li><span dir="ltr">Also found to be associated with  vasoconstrictive agents, endogenous hypercortisolism, Systemic corticosteroids,  SLE, Hypertension</span></li>
                                      </ul>
                                    </ul>
                                   <p><strong><u><h4>Ophthalmic Features</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr"><strong>Presentation: </strong></span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Unilateral blurred vision with a  relative scotoma in the central visual field</span></li>
                                       <li><span dir="ltr">Unilateral metamorphopsia and/or  micropsia</span></li>
                                       <li><span dir="ltr">Patients with extrafoveal involvement  may be asymptomatic</span></li>
                                      </ul>
                                     <li><span dir="ltr"><strong>Visual acuity:</strong></span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">V/A ranges from 6/5 to 6/60,  usually 6/9 – 6/12</span></li>
                                       <li><span dir="ltr">Acquired hyperopia</span></li>
                                       <li><span dir="ltr">Disparity between retinoscopy and  refraction</span></li>
                                      </ul>
                                   <p><img  height="144" src="images/csr_clip_image004.jpg"></p>
                                     <li><span dir="ltr"><strong>Fundus:</strong></span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">A round to oval sensory retinal  detachment is present at the posterior pole</span></li>
                                       <li><span dir="ltr">SRF: clear or turbid ±  Precipitates in the posterior surface of the sensory detachment</span></li>
                                       <li><span dir="ltr">In some small PED within the  serous detachment may be evident</span></li>
                                      </ul>
                                     <li><span dir="ltr"><strong>Other features:</strong></span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Impaired Dark adaptation</span></li>
                                       <li><span dir="ltr">Colour desaturation</span></li>
                                       <li><span dir="ltr">Increased retinal recovery time to  bright light</span></li>
                                       <li><span dir="ltr">Patients may present as bullous  inferior peripheral retinal detachment (non-rhegmatogenous), with a tract of  atrophic RPE from macular region (seen best with FFA)</span></li>
                                      </ul>
                                    </ul>
                                   <p><strong><u><h4>Investigations</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Fundus Fluorescein Angiography  (FFA)</span></li>
                                     <li><span dir="ltr">Slit Lamp Biomicroscopy</span></li>
                                     <li><span dir="ltr">Optical Coherence Tomography (  OCT)</span></li>
                                    </ul>
                                   <p><strong><u><h4>FFA</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr"><strong>Characteristic features:</strong></span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Smoke-stack appearance:</span></li>
                                       <ul style="list-style: disc;padding-left: 20px;">
                                         <li><span dir="ltr">Small hyperfluorescent spot in the  early phase due to leakage of dye through the RPE</span></li>
                                         <li><span dir="ltr">Fluorescein passes into the  subretinal space and ascends vertically until the upper border, like a  smoke-stack, in the late venous phase</span></li>
                                         <li><span dir="ltr">The dye then spreads laterally,  taking on a “mushroom” or “umbrella” configuration until entire area of  detachment is filled</span></li>
                                        </ul>
                                       <li><span dir="ltr">Ink-blot appearance: less common</span></li>
                                       <ul style="list-style: disc;padding-left: 20px;">
                                         <li><span dir="ltr">Hyperfluorescent spot in early  phase , which enlarges centrifugally until the entire detachment is filled with  dye</span></li>
                                        </ul>
                                      </ul>
                                    </ul>
                                   <p><img  height="192" src="images/csr_clip_image006.jpg">&nbsp;&nbsp;&nbsp;&nbsp;<img  height="192" src="images/csr_clip_image008.jpg">&nbsp;&nbsp;&nbsp;&nbsp;<img  height="192" src="images/csr_clip_image010.jpg"></p>
                                     <p align="center"><strong>Smoke stack appearance</strong></p>
                                   <p></p>
                                     <p>&nbsp;</p>
                                     <p><img  height="192" src="images/csr_clip_image012.jpg">&nbsp;&nbsp;&nbsp;&nbsp; <img  height="192" src="images/csr_clip_image014.jpg" alt="Acquired 3c">&nbsp;&nbsp;&nbsp;&nbsp;<img  height="192" src="images/csr_clip_image016.jpg"></p>
                                     <p align="center"><strong>Ink blot appearance</strong></p>
                                     <p></p>
                                     <p><strong><u><h4>Slit Lamp Biomicroscopy</h4></u></strong></p>
                                     <ul>
                                       <ul style="list-style: circle;padding-left: 20px;">
                                         <li><span dir="ltr">Transparent blister in the  posterior pole between neural retina and RPE</span></li>
                                         <ul style="list-style: circle;padding-left: 20px;">
                                           <li><span dir="ltr">Beam splitting as the light  traverses the serous space</span></li>
                                           <li><span dir="ltr">Increased distance between the  retinal vessels and their shadows</span></li>
                                           <li><span dir="ltr">Absent foveal reflex</span></li>
                                           <li><span dir="ltr">Small dot like deposits in the  posterior of retina which is believed to be the precipitates of plasma proteins  including fibrin</span></li>
                                         </ul>
                                       </ul>
                                     </ul>
                                     <p><strong><u><h4>OCT</h4></u></strong><br>
                                       Can be used to quantify the amount and extent of  subretinal fluid<br>
                         &nbsp;&nbsp;&nbsp;&nbsp;<img  height="150" src="images/csr_clip_image018.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="150" src="images/csr_clip_image019.jpg"></p>
                                     <p>&nbsp;&nbsp;&nbsp;&nbsp;<img  height="178" src="images/csr_clip_image021.jpg"></p>
                                     <p><strong><u><h4>Treatment</h4></u></strong></p>
                                     <ul style="list-style: disc;padding-left: 20px;">
                                       <li><span dir="ltr"><strong>Observation:</strong> 3-4 months in  most first episodes of unilateral CSCR</span></li>
                                       <li><span dir="ltr"><strong>Laser photocoagulation</strong></span></li>
                                       <li><span dir="ltr"><strong>Systemic beta blockers</strong>: may  have a beneficial role, but not well proven</span></li>
                                     </ul>          </td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><h2>MACULAR EDEMA</h2></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                   <ul style="list-style: disc;padding-left: 20px;" ><li><span dir="ltr">Because of failure of RPE cells  edema occurs in the eye.</span></li>
                                     <li><span dir="ltr">Macular edema comprises:- </span></li>
                                      <ul style="list-style: circle;padding-left: 20px;" ><li><span dir="ltr">Cystoid Macular Edema (CME)</span></li>
                                        <li><span dir="ltr">Neovascularisation</span></li>
                                        <li><span dir="ltr">Diabetic Edema</span></li>
                                       </ul>
                                   </ul>
                                   <p><strong><u><h4>CME</h4></u></strong>
                                     It is called CME because, it occurs in the macula and  forms cyst like spaces in the retinal tissue.</p>
                                 <u><h4>Etiology</h4></u></strong>
                              
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Vasculature and Inflammatory  diseases</span></li>
                                     <li><span dir="ltr">Extracellular accumulation of  fluid.</span></li>
                                    </ul>
                                  <h4>Symptoms</h4></u>
                                  <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Visual impairment</span></li>
                                     <li><span dir="ltr">Metamorphopsia</span></li>
                                     <li><span dir="ltr">Flickering</span></li>
                                     <li><span dir="ltr">Macropsia/Micropsia</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="158" src="images/macular_edema_clip_image001.jpg"></p>
                                     <p><strong><u><h4>Diagnosis</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr"><strong>Slit lamp examination</strong></span></li>
                                     <li><span dir="ltr"><strong>FFA -</strong> Fluorescein  angiography images show your Eye M.D. if any blood vessels are leaking and how  much leakage there is.</span></li>
                                     <li><span dir="ltr"><strong>OCT </strong>- Because macular edema  occurs inside the layers of retina tissue, you may have a test called  fluorescein angiography, or another called optical coherence tomography (OCT) to  help make an accurate diagnosis.</span></li>
                                     <li><span dir="ltr">It measures the thickness of the  retina and is also very sensitive at detecting swelling and fluid.</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="228" src="images/macular_edema_clip_image002.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="228" src="images/macular_edema_clip_image004.jpg"></p>
                                   <p><br>
                                     &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="166" src="images/macular_edema_clip_image006.jpg"></p>
                               <u><h4>Treatment</h4></u>
                                   <ul  style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Preventive</span></li>
                                     <li><span dir="ltr">Medical </span></li>
                                     <li><span dir="ltr">Surgical</span></li>
                                    </ul>
                              <u><h4>Preventive Treatment</h4></u>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Keep underlying Systemic diseases  well Controlled- </span></li>
                                      <ul style="list-style: circle;padding-left: 20px;">
                                        <li><span dir="ltr">DM</span></li>
                                        <li><span dir="ltr">HIV/CMV</span></li>
                                        <li><span dir="ltr">BP/Lipid control</span></li>
                                      </ul>
                                    </ul>
                              <u><h4>Medical Treatment </h4></u>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr"><strong>Topical Therapy </strong>– NSAIDS,  Steroids</span></li>
                                     <li><span dir="ltr"><strong>Systemic Therapy</strong>-NSAIDS, Steroids,  Diuretics</span></li>
                                     <li><span dir="ltr"><strong>Unique Posterior Segment Drug  Delivery</strong></span></li>
                                      <ul style="list-style: circle;padding-left: 20px;">
                                        <li><span dir="ltr">Trans-scleral</span></li>
                                        <li><span dir="ltr">Intravitreal – ( Kenalog,  Macugen,Lucentis, Avastin) </span></li>
                                        <li><span dir="ltr">Injection</span></li>
                                        <li><span dir="ltr">Implant (Biodegradable / Nonbiodegradable)</span></li>
                                      </ul>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="192" src="images/macular_edema_clip_image008.jpg"></p>
                                  <u><h4>Surgical Treatment</h4></u>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Nd:YAG vitreolysis</span></li>
                                     <li><span dir="ltr">Pars Plana Vitrectomy/Membrane  Peel</span></li>
                                     <li><span dir="ltr">Focal/Grid Photocoagulation</span></li>
                                     <li><span dir="ltr">Photo-Dynamic Therapy (PDT)</span></li>
                                    </ul>
                                  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="159" src="images/macular_edema_clip_image010.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="162" src="images/macular_edema_clip_image012.jpg"></p>
                                  <p>&nbsp;</p></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>


                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><h4>MACULAR HOLE</h4></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                 <ul style="list-style: disc;padding-left: 20px;">
                                   <li><span dir="ltr"><em>Synonyms: macular cyst, retinal  hole, retinal perforation</em></span></li>
                                   <li><span dir="ltr">A macular hole is a full-thickness  defect of retinal tissue.</span></li>
                                    <li><span dir="ltr">It runs from the internal limiting  membrane to the outer segment of the photoreceptor layer. It involves the  fovea, so affects central visual acuity (VA).</span></li>
                                   </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="175" src="images/macular_hole_clip_image002.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="175" src="images/macular_hole_clip_image004.jpg"></p>
                        <u>   <h4>Etiology</h4></u>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Usually idiopathic (&lt;10% have a  history of trauma). The most widely accepted theory suggests that age-related  focal shrinkage of the prefoveolar vitreous cortex causes traction on the  foveal area, leading to foveal detachment and subsequent macular hole  formation.</span></li>
                                     <li><span dir="ltr">Other risk factors include cystoid macular edema, retinal detachment, laser  injury, hypertension, very high myopia and diabetic retinopathy.</span></li>
                                    </ul>
                               <u><h4>Ophthalmic features</h4></u>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">It may rarely be an incidental  finding. Symptoms appear gradually over days/weeks:</span></li>
                                     <li><span dir="ltr">Distorted vision as well as visual  loss. </span></li>
                                     <li><span dir="ltr">Visual acuity (VA) will depend on  the site of the hole. </span></li>
                                     <li><span dir="ltr">Look for a tiny well-defined  'punched out' area of the macula which can be hard to detect. There may be  yellow-white deposits at the base with a grey margin around it representing  oedema. </span></li>
                                     <li><span dir="ltr">Slit Lamp Examinattion will show  'a round excavation with well-defined borders' interrupting the beam of the  slit lamp. </span></li>
                                     <li><span dir="ltr">Most patients also have a  semi-translucent tissue over the hole, which may be surrounded by a grey halo  caused by detachment of the retina. </span></li>
                                     <li><span dir="ltr"><strong>Gass Biomicroscopic  Classification</strong></span></li>
                                      <ul  style="list-style: circle;padding-left: 20px;">
                                        <li><span dir="ltr"><strong>Stage 1a</strong> Seen as a yellow  spot. This is not specific for macular hole - can be associated with central  serous chorioretinopathy, cystoid macular oedema, and solar maculopathy. </span></li>
                                        <li><span dir="ltr"><strong>Stage 1b</strong> Occult hole:  doughnut-shaped yellow ring (approximately 200-300 μm) centred on the foveola.  Approximately 50% of holes progress to stage 2. </span></li>
                                        <li><span dir="ltr"><strong>Stage 2</strong> Full thickness  macular hole (&lt;400 μm). Prefoveolar cortex usually separates eccentrically  creating a semi-transparent opacity, often larger than the hole, and the yellow  ring disappears. These generally progress to stage 3. </span></li>
                                        <li><span dir="ltr"><strong>Stage 3</strong> Holes &gt;400 μm  associated with partial vitreomacular separation. </span></li>
                                        <li><span dir="ltr"><strong>Stage 4</strong> Complete vitreous  separation from the entire macula and optic disc</span></li>
                                     </ul>
                                    </ul>
                               <u><h4>Investigations</h4></u>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Diagnosis is usually made  clinically; however, the following may be useful:</span></li>
                                     <li><span dir="ltr"><strong>Ocular coherence tomography</strong> (OCT) provides high-resolution cross-sectional imaging of the retina and is  useful in predicting prognosis.</span></li>
                                     <li><span dir="ltr"><strong>Fluorescein angiography </strong>(FA),  although not usually necessary, may be useful in differentiating macular holes  from cystoid macular oedema and choroidal neovascularisation (CNV). </span></li>
                                     <li><span dir="ltr">It typically shows a window defect  early in the angiogram that does not expand with time, and there is no leakage  or accumulation of dye. </span></li>
                                     <li><span dir="ltr">There may be Amsler grid  abnormalities. However, plotting small central scotomas is often difficult.</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="180" src="images/macular_hole_clip_image012.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="180" src="images/macular_hole_clip_image014.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="180" src="images/macular_hole_clip_image010.jpg"></p>
                                   <p style="vertical-align:top;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="350" src="images/macular_hole_clip_image008.jpg" align="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="139" src="images/macular_hole_clip_image006.jpg" align="top"></p>
                                   <p><strong><u><h4>Treatment</h4></u></strong></p>
                                   <ul  style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">About 50% of stage 1 holes resolve  spontaneously, but almost all stage 2 (and above) progress without surgery. </span></li>
                                     <li><span dir="ltr">The chosen surgery depends on the  staging of the hole. Surgical closure of the hole is considered up until stage  3 or 4 associated with a visual acuity (VA) of 6/18 or worse. If the macular  hole has been present for 1-3 years, then surgery is likely to work. If it has  been present for 5 years or longer, then results may be more variable. </span></li>
                                     <li><span dir="ltr"><strong>Vitrectomy </strong>may relieve  traction on the edge of the hole. The vitreous ± internal limiting membrane are  removed and a long-acting gas bubble is introduced to tamponade the macula back  into position. Short periods of postoperative prone posturing are being used in  some centres in selected patients to aid surgical procedures associated with  intraocular gas tamponade to achieve macular hole closure and there is  increasing evidence to support its use.</span></li>
                                     <li><span dir="ltr">Vitrectomy (with fluid-gas  exchange for stage 2, 3, and 4 holes) improves vision compared with  conservative treatment. Series of patients have been variously reported with  hole closure rates of 73-95%. Most patients' VA improves by two lines of the  Snellen chart.</span></li>
                                     <li><span dir="ltr">Success is also possible if the  hole is long-standing (6 months-2 years) or if the patient is aged &gt;80  years.</span></li>
                                     <li><span dir="ltr">Occasionally more than one  operation is required to close the hole. </span></li>
                                     <li><span dir="ltr">Standard vitrectomy with internal  limiting membrane (ILM) maculorrhexis (peeling) has been performed in patients  with stage 3 or 4 idiopathic macular holes. The retina is massaged to  approximate the edges of the hole as closely as possible. This technique gives  a good anatomical and functional result.</span></li>
                                     <li><span dir="ltr">For those patients who have a  condition that precludes surgery, visual rehabilitation may be the only option  with, for example, referral to low visual aids clinics if needed.</span></li>
                                    </ul>	      </td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><strong><h2>MACULAR PUCKER</h2></strong></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">A macular pucker is scar tissue  that has formed on the eye's macula, located in the center of the eye's  light-sensitive tissue called the retina. The macula provides the sharp,  central vision we need for reading, driving, and seeing fine detail. A macular  pucker can cause blurred and distorted central vision.</span></li>
                                      <li><span dir="ltr">Macular pucker is also known as  epiretinal membrane, preretinal membrane, cellophane maculopathy, retina  wrinkle, surface wrinkling retinopathy, premacular fibrosis, and internal  limiting membrane disease. </span></li>
                                     </ul>
                                    <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;<img  height="160" src="images/macular_pucker_clip_image002.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="160" src="images/macular_pucker_clip_image004.jpg"></p>
                                  <u><h4>Etiology</h4></u>
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">When the vitreous pulls away from  the retina, there is microscopic damage to the retina's surface (Note: This is  not a macular hole). When this happens, the retina begins a healing process to  the damaged area and forms scar tissue, or an epiretinal membrane, on the  surface of the retina. This scar tissue is firmly attached to the retina  surface. When the scar tissue contracts, it causes the retina to wrinkle, or  pucker, usually without any effect on central vision. However, if the scar  tissue has formed over the macula, our sharp, central vision becomes blurred  and distorted. </span></li>
                                     </ul>
                                  <u><h4>Ophthalmic features</h4></u>
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">Vision loss from a macular pucker  can vary from no loss to severe loss, although severe vision loss is uncommon. </span></li>
                                      <li><span dir="ltr">People with a macular pucker may  notice that their vision is blurry or mildly distorted, and straight lines can  appear wavy.</span></li>
                                      <li><span dir="ltr">&nbsp;They may have difficulty in seeing fine detail  and reading small print. </span></li>
                                      <li><span dir="ltr">There may be a gray area in the  center of your vision, or perhaps even a blind spot. </span></li>
                                     </ul>
                                    <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;<img  height="145" src="images/macular_pucker_clip_image006.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="145" src="images/macular_pucker_clip_image008.jpg"></p>
                                 <u><h4>Treatment</h4></u>
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">A macular pucker usually requires  no treatment. In many cases, the symptoms of vision distortion and blurriness  are mild, and no treatment is necessary. People usually adjust to the mild  visual distortion, since it does not affect activities of daily life, such as  reading and driving. Eye drops,&nbsp;  medications, nor nutritional supplements will improve vision distorted  from macular pucker. Sometimes the scar tissue--which causes a macular  pucker--separates from the retina, and the macular pucker clears up. </span></li>
                                      <li><span dir="ltr">Rarely, vision deteriorates to the  point where it affects daily routine activities. However, when this happens,  surgery may be recommended. This procedure is called a vitrectomy in which the vitreous  gel is removed to prevent it from pulling on the retina and replaced with a  salt solution (Because the vitreous is mostly water, you will notice no change  between the salt solution and the normal vitreous). Also, the scar tissue which  causes the wrinkling is removed. A vitrectomy is usually performed under local  anesthesia.</span></li>
                                      <li><span dir="ltr">After the operation, you will need  to use medicated eye drops to protect against infection</span></li>
                                     </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; <img  height="168" src="images/macular_pucker_clip_image009.jpg"></p>	        
                                   <p>&nbsp;</p></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><strong><h2>RETINITIS PIGMENTOSA</h2></strong></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                  <p>Retinitis pigmentosa is the most common of a group of  hereditary progressive retinal degenerations or dystrophies. There is  considerable variation and overlap among the various forms of retinitis  pigmentosa. Common to all of them is progressive degeneration of the retina,  specifically of the light receptors, known as the rods and cones. The rods of  the retina are involved earlier in the course of the disease, and cone  deterioration occurs later. In this progressive degeneration of the retina, the  peripheral vision slowly constricts and central vision is usually retained  until late in the disease. </p>
                                  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;<img  height="178" src="images/retinitis_pigmentosa_clip_image002.jpg"></p>
                                <u><h4>Etiology</h4></u>
                                  <ul style="list-style: disc;padding-left: 20px;">
                                    <li><span dir="ltr">Retinitis pigmentosa is an  inherited condition which involves both eyes. If it starts in one eye, the  other eye usually develops the same condition in a number of years. Most cases  are familial, inherited in a variety of ways, including dominant, recessive,  and sex-linked recessive. Some cases are sporadic and lack a family history of  the disease. </span></li>
                                    </ul>
                               <u><h4>Ophthalmic features</h4></u>
                                  <ul style="list-style: disc;padding-left: 20px;">
                                    <li><span dir="ltr">Since retinitis pigmentosa begins  as rod degeneration, the patient first notices increasing difficulty in night  vision, followed by difficulty seeing in the periphery. Slowly progressive  constriction of the visual field leads to tunnel vision. A small area of  central vision in both eyes usually persists for years. Generally night  blindness precedes tunnel vision by years or even decades. Total blindness  eventually ensues in most cases. The age of appearance of legal blindness  ranges from as early as childhood to as late as the 40s. </span></li>
                                    </ul>
                                  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;<img  height="182" src="images/retinitis_pigmentosa_clip_image003.jpg"></p>
                                 <h4>Diagnosis</h4></u>
                                  <ul style="list-style: disc;padding-left: 20px;">
                                    <li><span dir="ltr">The history (especially the  possibility of retinitis pigmentosa appearing in other family members) and  complaints of the patient may make one suspect RP, it is primarily diagnosed by  examination. The patient may complain of difficulty seeing at night or in low  light condition. At some point, the ophthalmologist observes relatively  characteristic bone spicule pigment during the fundus examination </span></li>
                                    <li><span dir="ltr"><strong>Visual fields </strong>-will find  defects in the peripheral (side vision) with the degree of loss related to  defects in relation to the damage occurring in this disease. Over time, the  visual field may reduce to a small central island of vision causing  "tunnel vision." The final progression may be the complete loss of  the remaining central vision. </span></li>
                                    <li><span dir="ltr"><strong>Electoretinogram </strong>-Responses  to flashes of light are measured via electrodes placed on the surface of the  eye. It is a painless test. The electroretinogram(ERG), in conjunction with the  visual field exam, will usually make the diagnosis. This will also determine if  there is any cone involvement.</span></li>
                                    <li><span dir="ltr">Recently, <strong>gene testing</strong> for  defects is being done to clarify the basic cause for RP and assist in  ultimately finding a treatment</span></li>
                                    </ul>
                                  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;<img  height="188" src="images/retinitis_pigmentosa_clip_image005.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="188" src="images/retinitis_pigmentosa_clip_image007.jpg"></p>
                                  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;<img  height="158" src="images/retinitis_pigmentosa_clip_image009.jpg"></p>
                              <u><h4>Treatment</h4></u>
                                  <ul style="list-style: disc;padding-left: 20px;">
                                    <li><span dir="ltr">As of now there is no specific  cure for retinitis pigmentosa. For years, vitamin A therapy has been  recommended for many RP patients, based on research dating back to the early  1990s. A randomized, controlled trial of vitamins A and E found that 15,000 IU  a day of vitamin A palmitate could slow the course of the condition among  adults with typical forms of RP. Vitamin E, however, at a 400 IU a day dose  appeared to have an adverse effect on the course of RP in the same study.</span></li>
                                    <li><span dir="ltr">Another study among adult patients  with RP has shown that an omega-3-rich diet containing docosahexaenoic acid can  further slow disease progression. Such a diet includes one to two 3-ounce  servings per week of oily fish such as salmon, tuna, herring, mackerel, or  sardine</span></li>
                                    </ul>
                                  </td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><strong><h2>TOXOPLASMOSIS</h2></strong></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                    <p>Toxoplasmosis is a disease  provoked by the obligate intracellular protozoan Toxoplasma gondii. It is found  in a variety of mammal and bird hosts. The most common intermediate host is the  cat. It is one of the most frequent causes of retinochoroiditis in humans, with  more than 60 percent of the United    States population and up to 75 percent of  the world's general population possessing some seropositive findings</p>
                                    <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;<img  height="190" src="images/toxoplasmosis_clip_image002.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="190" src="images/toxoplasmosis_clip_image004.jpg"></p>
                                    <u><h4>Etiology</h4></u>
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">Human infection may occur from  ingestion of contaminated or undercooked meat and dairy products, direct or  indirect ingestion of cat feces and transplacental transmission from an  infected mother to the fetus. Toxoplasmosis can only be transmitted to a fetus  during maternal parastemia. Congenital toxoplasmosis accounts for the majority  of cases encountered in clinical practice.</span></li>
                                      <li><span dir="ltr">In most cases, the body is primed  for infection or toxoplasmosis reactivation by an immune system failure. This  may occur following contraction of human immunodeficiency syndrome (HIV) or  with medical immunosupression following organ transplantation.</span></li>
                                     </ul>
                            
                                    <!-- <div style=" float:left;"> -->
                                    <div style="">
                                      &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="360" src="images/toxoplasmosis_clip_image008.jpg">
                                   </div>
                                    <div >
                                     <img width="324" height="192" src="images/toxoplasmosis_clip_image006.jpg"><img  height="204" src="images/toxoplasmosis_clip_image010.jpg">
                                    </div>
                        
                                   <u><h4>Ophthalmic Features</h4></u>
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">The symptoms associated with  ocular toxoplasmosis include unilateral, mild ocular pain, blurred vision and  new onset of floating spots. Patients often describe their vision as hazy. </span></li>
                                      <li><span dir="ltr">Clinical findings may include  granulomatous iritis, vitritis, optic disc swelling, neuroretinitis, vasculitis  and retinal vein occlusion in the vicinity of the inflammation, in the actively  involved eye. </span></li>
                                      <li><span dir="ltr">Funduscopically, active  toxoplasmosis presents with white-yellow, choreoretinal lesions and vitreous  cells. There may be old, inactive lesions in the fellow eye. </span></li>
                                      <li><span dir="ltr">Toxoplasmosis can produce cystoid  macular edema and choroidal neovascularization.</span></li>
                                     </ul>
                                    <u><h4>Treatment</h4></u>
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">The goal of management is twofold:  (1) eradicate the parasite and (2) suppress the inflammatory response.</span></li>
                                      <li><span dir="ltr">Alternative antibiotic treatments  include: (1) clindamycin, 300mg, PO QID used with sulfadiazine, for four to six  weeks, (2) tetracycline, 2g loading then 250mg PO QID and sulfadiazine for four  to six weeks, or (3) trimethoprim/sulfamethoxazole 160/800mg, one tablet PO  BID, with or without clindamycin or prednisone, for the same duration.</span></li>
                                      <li><span dir="ltr">In otherwise normal individuals,  after beginning antibiotic therapy, add oral steroids at a dose of 20 to 80mg PO daily for four to six weeks. Periocular steroids are  never indicated. Oral steroids without systemic antibiotics are expressly  contraindicated.</span></li>
                                     </ul>
                                   <p>&nbsp;</p>	        </td>
                                 <td width="30" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">
                              
                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                   <td colspan="3" align="center">&nbsp;</td>
                                 </tr>
                                 <tr>
                                   <td  align="left" valign="top">&nbsp;</td>
                                   <td  align="left" valign="top" class="Page_title"><h2>LATTICE DEGENERATION</h2></td>
                                   <td  align="left" valign="top">&nbsp;</td>
                                 </tr>
                                 <tr>
                                   <td  align="left" valign="top">&nbsp;</td>
                                   <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                    <p>Lattice degeneration is a disease  of the eye where peripheral retina becomes atrophic in a lattice pattern and  may develop tears / breaks / holes, which may further progress to retinal  detachment. It is an important cause of retinal detachment in young myopic  individuals. The cause is not known but pathology reveals vascular  insufficiency resulting in ischemia and fibrosis.</p>
                                    <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="152" src="images/lattice_degenration_clip_image002.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="152" src="images/lattice_degenration_clip_image004.jpg"></p>
                                   <u><h4>Etiology</h4></u>
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">The etiology of lattice is  questionable. It appears to be due to dropout of peripheral retinal capillaries  with resulting ischemia, which induces thinning of all retinal layers. There is  sclerosis of the larger vessels, with their lumen being filled with extracellular  glial tissue, giving lattice degeneration its characteristic fibrotic  appearance.</span></li>
                                      <li><span dir="ltr">Lattice degeneration occurs in  eight to 11 percent of the general population. It presents as a linear trail of  fibrosed vessels within atrophied retina in a "lattice" pattern. It  nearly always runs circumferentially between the equator and the ora serrata</span></li>
                                    </ul>
                                    <u><h4>Ophthalmic features</h4></u>
                                    <ul  style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">Typical lattice consists of  sharply demarcated spindle-shaped areas of retinal thinning usually located  between the equator of the retina and the posterior border of the vitreous  base. This is more frequently located in the temporal half of the retina and is  seen more superiorly than inferiorly.</span></li>
                                      <li><span dir="ltr">Atypical lattice is characterised  by radial lesions which appear continuous with the peripheral blood vessels.  This type is typically seen in patients with Stickler syndrome.</span></li>
                                    </ul>
                                    <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="156" src="images/lattice_degenration_clip_image006.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="156" src="images/lattice_degenration_clip_image008.jpg"></p>
                                <u><h4>Treatment</h4></u>
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">The main concern with lattice  degeneration is the chance of progression to rhegmatogenous retinal detachment.  With many types of retinal breaks, the area is often prophylactically sealed  with laser photocoagulation or cryoretinopexy to prevent this. In lattice  degeneration alone, prophylactic treatment is not practical in that the risk of  detachment is only 0.1 to 0.7 percent in the phakic eye. Atrophic holes in  phakic eyes with lattice degeneration also do not require prophylactic  treatment, as the risk of progression to detachment is two percent or less.</span></li>
                                      <li><span dir="ltr">Furthermore, prophylactic  treatment of lattice lesions in eyes with greater than 6.00D of myopia yields  no benefit. These lesions need only routine, yearly monitoring with the patient  educated about signs and symptoms of retinal detachment. However, a linear  tractional tear forming at the posterior border of a lattice lesion has about a  37 percent risk of progression to retinal detachment and therefore should  receive prophylactic therapy.</span></li>
                                   </ul>	        <p>&nbsp;</p></td>
                                   <td  align="left" valign="top">&nbsp;</td>
                                 </tr>
                                 <tr>
                                   <td colspan="3" align="left" valign="top">&nbsp;</td>
                                 </tr>
                                 <tr>
                                   <td colspan="3" align="center">&nbsp;</td>
                                 </tr>
                                </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                   <td colspan="3" align="center">&nbsp;</td>
                                 </tr>
                                 <tr>
                                   <td  align="left" valign="top">&nbsp;</td>
                                   <td  align="left" valign="top" class="Page_title"><strong><h2>FLOATERS & FLASHES</h2></strong></td>
                                   <td  align="left" valign="top">&nbsp;</td>
                                 </tr>
                                 <tr>
                                   <td  align="left" valign="top">&nbsp;</td>
                                   <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr"><strong>Floaters</strong> - Small specks or  clouds moving in your field of vision are called floaters. You may see them  more clearly when looking at a plain background, such as a blank wall.</span></li>
                                      <li><span dir="ltr"><strong>Flashes</strong> -When the vitreous  gel inside your eye rubs or pulls on the retina, you may see what look like  flashing lights or lightning streaks. You may have experienced this same  sensation if you have ever been hit in the eye and seen "stars". </span></li>
                                    </ul>
                                    <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="174" src="images/floaters_flashes_clip_image002.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;<img  height="174" src="images/floaters_flashes_clip_image004.jpg"></p>
                               <u><h4>Etiology</h4></u>
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">Floatres - Posterior vitreous  detachments or PVDs are common causes of vitreous floaters. Far less commonly,  these symptoms can be associated with retinal tears or detachments that may be  linked to PVDs.</span></li>
                                      <li><span dir="ltr">Flashes&nbsp; - Ordinarily, light entering your eye stimulates  the retina. This produces an electrical impulse, which the optic nerve transmits to the brain. The brain then interprets this impulse as light or some  type of image. When the retina is tugged, torn or detached from the back of the  eye, a flash or flicker of light commonly is noticed. Depending on the extent  of the tear or detachment, these flashes of light might be short-lived or  continue indefinitely until the retina is repaired.</span></li>
                                      <li><span dir="ltr">Vitreous detachments with  accompanying vitreous floaters also may occur in circumstances such as:</span></li>
                                      <li><span dir="ltr">Inflammation in the eye's  interior-</span></li>
                                      <li><span dir="ltr">Nearsightedness</span></li>
                                      <li><span dir="ltr">Cataract surgery</span></li>
                                      <li><span dir="ltr">YAG laser eye surgery</span></li>
                                      <li><span dir="ltr">Diabetes (diabetic retinopathy)</span></li>
                                      <li><span dir="ltr">CMV retinitis</span></li>
                                    </ul>
                                   <u><h4>Ophthalmic Features</h4></u>
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">You should see your  ophthalmologist as soon as possible if: </span></li>
                                       <ul  style="list-style: circle;padding-left: 20px;">
                                         <li><span dir="ltr">One new, large floater or  "showers" of floaters appear suddenly </span></li>
                                         <li><span dir="ltr">You see sudden flashes of light </span></li>
                                       </ul>
                                      <li><span dir="ltr">You notice other symptoms, such as  the loss of side vision.</span></li>
                                      <li><span dir="ltr">Floaters and flashes of light become  more common as we grow older. While not all floaters and flashes are serious,  you should always have a medical eye examination by an ophthalmologist to make  sure there has been no damage to your retina</span></li>
                                    </ul>
                                    <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="152" src="images/floaters_flashes_clip_image006.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="152" src="images/floaters_flashes_clip_image008.jpg"></p>
                                   <u><h4>Treatment</h4></u>
                                    <ul style="list-style: disc;padding-left: 20px;">
                                      <li><span dir="ltr">Because there's a risk of a torn  retina, call your ophthalmologist if a new floater appears suddenly. Floaters  can get in the way of clear vision, which may be quite annoying, especially  when reading. </span></li>
                                      <li><span dir="ltr">While some floaters may remain in  your vision, many of them will fade over time and become less bothersome. Even  if you have had some floaters for years, you should have an eye examination  immediately if you notice new ones. </span></li>
                                      <li><span dir="ltr">There is no specific treatment for  separation of the vitreous gel from the retina. Medications can be used to help  alleviate symptoms from migraine. Laser therapy or surgery may be required for  retinal tears. </span></li>
                                      <li><span dir="ltr">The treatment for floaters and  flashes depends on the underlying condition. While not all floaters and flashes  are serious, you should always have a medical eye examination by an  ophthalmologist to make sure there has been no damage to your retina.</span></li>
                                    </ul>
                                   <p>&nbsp;</p>	        
                                   </td>
                                   <td  align="left" valign="top">&nbsp;</td>
                                 </tr>
                                 <tr>
                                   <td colspan="3" align="left" valign="top">&nbsp;</td>
                                 </tr>
                                 <tr>
                                   <td colspan="3" align="center">&nbsp;</td>
                                 </tr>
                                </tbody></table>

                           </div>
                        </div>


                     </div>
                  </div>
               </div>
            </div>
         </section>






       </div>
       <!-- Page Content End -->

       <!-- footer -->
       <footer class="footer site-footer">
          <div class="footer-wrap pbmit-footer-big-area">
             <div class="container">
                <div class="row align-items-center">
                   <div class="col-md-9">
                      <div class="d-md-flex align-items-center justify-content-between">
                         <div class="pbmit-footer-logo">
                            <img class="pbmit-main-logo" src="images/logo.jpg" alt="Cardioly Demo1">
                         </div>
                         <div class="d-md-flex">
                            <div class="pbmit-footer-boxes col-md-6">
                               <div class="pbmit-footer-contact-info">
                                  <div class="pbmit-footer-contact-info-inner d-flex align-items-center">
                                     <!-- <i class="pbmit-base-icon-location"></i> -->
                                     <i class="fa fa-map-marker" aria-hidden="true"></i>
                                     <div class="pbmit-footer-contact-info-wrap">
                                        <span class="pbmit-label">Our Clinic Address</span> 306,marvella business hub,<br/>
Opp to PAL RTO<br/>
                                       Pal Hazira Road surat-395009
                                     </div>
                                  </div>
                               </div>
                            </div>
                            <div class="pbmit-footer-boxes col-md-6">
                               <div class="pbmit-footer-contact-info">
                                  <div class="pbmit-footer-contact-info-inner d-flex align-items-center">
                                    <i class="fa fa-phone" aria-hidden="true"></i>
                                     <!-- <i class="pbmit-base-icon-phone"></i> -->
                                     <div class="pbmit-footer-contact-info-wrap">
                                        <span class="pbmit-label">Phone Number</span> +91 79 9072 3404
                                     </div>
                                  </div>
                               </div>
                            </div>
                         </div>
                      </div>
                   </div>
                   <div class="col-md-3 pbmit-footer-social-icon">
                      <ul class="pbmit-social-links">
                         <li class="pbmit-social-li pbmit-social-facebook">
                            <a href="https://www.facebook.com/profile.php?id=100054410862900&mibextid=LQQJ4d" target="_blank" class="d-flex align-items-center justify-content-center">
                               <span>
                                <i class="fa fa-facebook-f"></i>
                            </span>
                            </a>
                         </li>
                         <li class="pbmit-social-li pbmit-social-twitter">
                            <a href="https://www.instagram.com/dr.nikita_eye_hospital/?igshid=YmMyMTA2M2Y%3D" target="_blank" class="d-flex align-items-center justify-content-center">
                               <span>
                                <i class="fa fa-instagram"></i>
                            </span>
                            </a>
                         </li>


                      </ul>
                   </div>
                </div>
             </div>
          </div>
          <div class="pbmit-footer-widget-area">
             <div class="container">
                <div class="row">
                   <div class="col-md-6 col-lg-3">
                      <div class="widget pbmit-float-menu">
                         <h3 class="widget-title">Information</h3>
                         <ul>
                            <li class="menu-item ">
                               <a href="index.html">Home</a>
                            </li>
                            <li class="menu-item ">
                               <a href="/inquiry.php">Inquiry</a>
                            </li>
                            <!-- <li class="menu-item ">
                               <a href="#">Service</a>
                            </li> -->
                            <li class="menu-item ">
                               <a href="overview.html">Overview</a>
                            </li>
                            <li class="menu-item ">
                               <a href="patient.html">Patient Information</a>
                            </li>
                            <li class="menu-item ">
                               <a href="technology.html">Technology</a>
                            </li>
                            <li class="menu-item ">
                               <a href="patient-services.html">Patient Services</a>
                            </li>
                            <li class="menu-item ">
                               <a href="infrastructure.html">Infrastructure</a>
                            </li>
                            <li class="menu-item ">
                               <a href="patient-education.html">Patient Education</a>
                            </li>
                         </ul>
                      </div>
                   </div>
                   <div class="col-md-6 col-lg-3">
                      <div class="pbmit-two-widget">
                         <div class="widget">
                            <h3 class="widget-title">Patient Education</h3>
                            <ul class="pbmit-rpw-list">
                               <li>
                                  <a href="patient-education.html">
                                     <span class="pbmit-rpw-img">
                                        <img src="images/debetic_info.png" class="img-fluid" alt="">
                                     </span>
                                  </a>
                                  <span class="pbmit-rpw-content">
                                     <span class="pbmit-rpw-title"><a href="patient-education.html">Diabetic Retinopathy is eye damage caused by diabetes-related high blood sugar levels.</a>
                                     </span>
                                  </a></span>
                                     
                                  </span>
                               </li>
                               <li>
                                  <a href="patient-education.html">
                                     <span class="pbmit-rpw-img">
                                        <img src="images/retinal_detachment_clip_image004.jpg" class="img-fluid" alt="">
                                     </span>
                                  </a>
                                  <span class="pbmit-rpw-content">
                                     <span class="pbmit-rpw-title">
                                        <a href="patient-education.html">Retinal detachment is a medical emergency in which the retina separates from the inner surface of the eye.</a>
                                     </span>
                                     
                                  </span>
                               </li>
                            </ul>
                         </div>
                      </div>
                   </div>
                   <div class="col-md-6 col-lg-3">
                      <div class="widget">
                         <h3 class="widget-title">Newsletter</h3>
                         <div>Sign up today for hints, tips and the latest product news
                            <div class="pbmit-footer-newsletter">
                              <form action="submit_email.php" method="post">
                              <input type="email" name="email" placeholder="Your email address" required>	
                              <button type="submit" name="submit">Submit <i class="fa fa-paper-plane"></i></button>
                              </form>
                            </div>
                         </div>
                      </div>
                   </div>
                   <div class="col-md-6 col-lg-3">
                      <div class="widget">
                         <h3 class="widget-title">Opening Hours</h3>
                         <ul class="pbmit-timelist-list">
                            <li><span class="pbmit-timelist-li-title">Mon </span>
                               <span class="pbmit-timelist-li-value">10:30 am –  2pm  ,  5pm - 8pm</span>
                            </li>
                            <li><span class="pbmit-timelist-li-title">Tues</span>
                               <span class="pbmit-timelist-li-value">10:30 am –  2pm  ,  5pm - 8pm</span>
                            </li>
                            <li><span class="pbmit-timelist-li-title">Wed</span>
                               <span class="pbmit-timelist-li-value">10:30 am –  2pm  ,  5pm - 8pm</span>
                            </li>
                            <li><span class="pbmit-timelist-li-title">Thurs</span>
                               <span class="pbmit-timelist-li-value">10:30 am –  2pm  ,  5pm - 8pm</span>
                            </li>             <li><span class="pbmit-timelist-li-title">Fri</span>
                               <span class="pbmit-timelist-li-value">10:30 am –  2pm  ,  5pm - 8pm</span>
                            </li>    <li><span class="pbmit-timelist-li-title">Sat</span>
                               <span class="pbmit-timelist-li-value">10:30 am –  2pm  ,  5pm - 8pm</span>
                            </li>
                            <li><span class="pbmit-timelist-li-title">Sunday</span>
                               <span class="pbmit-timelist-li-value">Closed</span>
                            </li>
                         </ul>
                      </div>
                   </div>
                </div>
             </div>
          </div>
          <div class="pbmit-footer-section pbmit-bg-color-global">
             <div class="container">
                <div class="pbmit-footer-text-inner">   
                   <div class="pbmit-footer-copyright-box"> © 2023  Dr.Nikita's Eye Hospital                
                      <!-- <a href="index.html">Cardioly Demo1</a>, All Rights Reserved. -->
                   </div>
                   <div class="pbmit-footer-copyright-box mt-sm-3">
                      <ul>
                         <li class="pbmit-footer-menu li">
                            <a href="faq.html">Privacy Policy</a>
                         </li>         
                         <li class="pbmit-footer-menu li">
                            <a href="overview.html">Overview</a>
                         </li>    
                         <li class="pbmit-footer-menu li">
                            <a href="contact.html">Contact Us</a>
                         </li>
                      </ul>
                   </div>
                </div>
             </div>
          </div>	
       </footer>
       <!-- footer End -->
       
    </div>
    <!-- page wrapper End -->

    <!-- Search Box Start Here -->
    <!-- <div class="pbmit-search-overlay">
       <div class="pbmit-icon-close"></div>
       <div class="pbmit-search-outer"> 
          <form class="pbmit-site-searchform">
             <input type="search" class="form-control field searchform-s" name="s" placeholder="Type Word Then Press Enter">
             <button type="submit">
                <i class="pbmit-base-icon-search-1"></i>
                
            </button>
          </form>
       </div>
    </div> -->
 <!-- Search Box End Here -->

    <!-- JS
       ============================================ -->
    <!-- jQuery JS -->
    <script src="js/jquery.min.js"></script>
    <!-- Popper JS -->
    <script src="js/popper.min.js"></script>
    <!-- Bootstrap JS -->
    <script src="js/bootstrap.min.js"></script>
    <!-- jquery Waypoints JS -->
    <script src="js/jquery.waypoints.min.js"></script>
    <!-- jquery Appear JS -->
    <script src="js/jquery.appear.js"></script>
    <!-- Numinate JS -->
    <script src="js/numinate.min.js"></script>
    <!-- Slick JS -->
    <script src="js/swiper.min.js"></script>
    <!-- Magnific JS -->
    <script src="js/jquery.magnific-popup.min.js"></script>
    <!-- Circle Progress JS -->
    <script src="js/circle-progress.js"></script> 
    <!-- countdown JS -->
    <script src="js/jquery.countdown.min.js"></script> 
    <!-- AOS -->
    <script src="js/aos.js"></script>
    <!-- Scripts JS -->
    <script src="js/scripts.js"></script><a href="#" class="scroll-to-top">
        <!-- <i class="pbmit-base-icon-up-open-big"></i>
        <i class="pbmit-base-icon-up-open-big"></i> -->
        <i class="fa fa-angle-up"></i>
    </a>
    <!-- Revolution JS -->
    <script src="revolution/rslider.js"></script>
    <script src="revolution/rbtools.min.js"></script>
    <script src="revolution/rs6.min.js"></script>

    <script>
      // Get all the tab content elements
      var tabContents = $('.tab-content');
      
      // Get the tab container element
      var tabContainer = $('#tab-container');
      
      // Get all the tab links
      var tabLinks = tabContainer.find('a');
      
      // Loop through each tab link and add a click event listener
      tabLinks.on('click', function(e) {
         e.preventDefault();
         var tab = $(this).parent();
         var tabContentIndex = tab.index();
         tab.siblings().removeClass('post-active');
         tab.addClass('post-active');
         tabContents.each(function(index) {
            if (index === tabContentIndex) {
               $(this).addClass('active').show();
            } else {
               $(this).removeClass('active').hide();
            }
         });
      });
       </script>
 
</body></html>